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ABSTRACT
Phonation Threshold Pressure and Phonation Threshold Flow in Rabbits Treated
With Inhaled Corticosteroids Versus Controls
Heidi Joan Robison
Department of Communication Disorders, BYU
Master of Science
This thesis is part of a larger series of studies being conducted by Kristine Tanner, PhD,
Associate Professor in the Department of Communication Disorders at Brigham Young
University (BYU). The larger project is funded by the National Institute on Deafness and Other
Communication Disorders at the National Institutes of Health. This thesis primarily investigated
the effects of combination inhaled corticosteroids (ICs) on aerodynamic measures of the voice.
In recent years, an increase in the localized laryngeal side effects from IC treatment, including
dysphonia, have been reported. This study employed a between-groups experimental design,
with two groups of rabbit larynges having been exposed to either ICs or nebulized isotonic saline
two times each day for eight weeks at The University of Utah. For this study, the independent
variable is group condition (i.e., IC versus saline) and the dependent variables are two
aerodynamic measurements made at the onset of phonation using a benchtop experimental setup,
namely phonation threshold pressure (PTP; cmH2O) and phonation threshold flow (PTF; L/min).
The results of this study indicate a significant difference in PTP and PTF between vocal folds
treated with IC as compared to vocal folds treated with nebulized isotonic saline solution.
Implications of this study suggest negative changes in the voice due to IC treatment.

Keywords: phonation threshold pressure (PTP), phonation threshold flow (PTF), inhaled
corticosteroids, rabbit phonation, benchtop model, asthma
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DESCRIPTION OF THESIS STRUCTURE AND CONTENT
This thesis, Phonation Threshold Pressure and Phonation Threshold Flow in Rabbits
Treated With Inhaled Corticosteroids Versus Controls, is written in a journal style format. This
paper was part of a larger, long-term project being conducted by Dr. Kristine Tanner. Funding
was received for the project from the David O. McKay School of Education and the National
Institute on Deafness and Other Communication Disorders, National Institutes of Health
(1R01DC016269-01A1).
The preliminary pages of the thesis reflect requirements for submission to the university.
This thesis contains one reference list found before the appendices. The corresponding annotated
bibliography is found in Appendix A. Appendix B contains materials necessary for the data
collection and analysis. Appendix C contains LabChart ™ protocol and computer set-up
information. Appendix D includes protocol for pressure calibration in LabChart ™ with
Appendix E containing protocol for flow calibration in LabChart ™. Appendix F details rabbit
tissue dissection and preparation protocol. Appendix G includes data acquisition protocol and
Appendix H contains data segmentation and analysis protocol.
Data from this thesis were accepted as a poster presentation for the Annual Convention of
the American Speech-Language-Hearing Association in San Diego, CA (Convention canceled
due to Covid-19). The data will from this thesis will be used in the long-term study conducted by
Dr. Kristine Tanner and ultimately submitted to a peer-reviewed journal with the author of this
thesis listed as one of multiple coauthors.
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Introduction
In the most recent report from the Centers for Disease Control (CDC), approximately
7.7% of the total population, or 1 out of every 13 individuals of all ages in the United States has
an asthma diagnosis (Centers for Disease Control, 2018). Asthma is a lung disease that affects
people of all ethnicities, genders, living environments, and other demographic variables. It is
reported that over 40 million adults and children in the US suffer from chronic pulmonary
diseases, including 25 million cases of asthma (Akinbami & Lie, 2011; Mannino et al., 2000).
For example, New Zealand has reported one of the highest prevalence of asthma diagnosis in the
world, affecting approximately 15%-20% of children and adults (Sahrawat et al., 2014).
According to Sahrawat et al. (2014), asthma is the third highest cause of disease-related longterm disability in New Zealand.
One of the hallmark characteristics of asthma is inflammation of the bronchi (Ihre et al.,
2004). Inflammation causes mucus to collect in the airway, causing many individuals to cough
and clear their throats frequently to achieve their adequate voice for communication. Asthma
attacks causing coughing, shortness of breath, chest tightness or pain among other symptoms
vary from person to person and can be triggered by exercise, occupational irritants, or allergies
(Mayo Foundation for Medical Education and Research, 2020).
Inhaled Corticosteroid Treatment
In an effort to reduce inflammation and the effects of asthma on quality of life, inhaled
corticosteroids (ICs) are commonly prescribed. Short-acting inhalers, or rescue inhalers are used
during asthma attacks as a quick relief, while longer acting inhalers are used provide control of
asthma symptoms (Dong et al., 2015). The goal of IC treatment is to decrease the chronic
inflammation of asthma and reduce airway hyperresponsiveness. This goal is targeted by
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combining corticosteroids with long-acting beta agonist (LABA). Corticosteroids are
bronchodilators used to reduce airway inflammation. Additionally, LABA are bronchodilators,
but also inhibit mast (white blood) cell release and may reduce sensory nerve activation. The
combination of these two drugs addresses the pathophysiology of asthma and is commonly
referred to as combination IC. (Barnes, 2002). The positive effects of IC treatment can be seen as
early as 30 minutes to two hours after treatment (Sahrawat et al., 2014), reducing the frequency
and severity of asthma attacks. IC treatment have been effective in reducing morbidity and
improving the health of asthma patients allowing many to live a normal life with improved lung
function and reduced exacerbations (Barnes, 2010; Erickson & Sivasankar, 2010). While there
are many advantages to IC treatment, the prevalence of systemic and local side effects must be
considered when using ICs to treat asthma.
Systemic side effects occur as a consequence of up to 80% of IC treatment dosage being
swallowed. These side effects include glaucoma, cataracts, osteoporosis, bruising, adrenal
suppression, growth suppression, psychiatric disturbances, and metabolic abnormalities (Barnes,
2010; Bhalla et al., 2008). Local side effects include pharyngitis, laryngitis, throat irritation,
oropharyngeal candidiasis, and dysphonia (Barnes, 2010; Bhalla et al., 2008; Sahrawat et al.,
2014). The degree of local side effects varies depending on the dose and frequency of IC
treatment. While all of these side effects of IC treatment are important to consider, the most
common complaint from up to 50%-55% of individuals using ICs is hoarseness (Ihre et al., 2004;
Hassen & Hasseba, 2016).
Pulmonologists, allergists, otolaryngologists, and pharmacologists as well as
corresponding literature on asthma indicate that in addition to cough and throat clearing, vocal
fatigue and different dysphonic voice qualities are associated with IC use (Ihre et al., 2004).
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Dysphonia is characterized by a change in pitch, vocal quality, loudness, or effort that can impair
functional living and quality of life (Galván & Guarderas, 2012). Dysphonia impacts
individuals’ ability to effectively communicate in their home, work, and social environments. IC
treatment induced dysphonia is likely caused by deposits of the medication in the oropharynx
after administration as it has been reported that up to 80% of the treatment dosage may be
deposited in the oropharynx (Erickson & Sivasankar, 2010; Galván & Guarderas, 2012).
To prevent systemic and local side effects, researchers have suggested that when taking
ICs in large doses (>800 μg), individuals should rinse with mouthwash immediately after
treatment and use a spacer device, a holding chamber attached to the inhaler to slow the delivery
of medication (Barnes, 2010). However, rinsing with mouthwash and using a spacer does not
address the potential changes leading to dysphonia at or below the level of the vocal folds caused
by IC treatment. More research needs to be completed on effective prevention of side effects
from the treatment; however human research limitations must be addressed. For example, IC
treatment cannot be withheld from those who need them, so it is difficult to determine why
certain individuals experience what seems to be IC-associated voice disorders (Erickson &
Sivasankar, 2010). For this reason, alternative models have been utilized in studying the effects
of IC on the voice which include in vivo and ex vivo animal models.
Animal Models of Human Phonation
Considerable research has assessed the effectiveness of IC for treating asthma. However,
only recently have the local side effects of IC treatment been a topic of research. Because of the
invasive nature of studying the human voice, alternative methodologies including animal,
cadaveric, and computational models have been used throughout the past decade to further our
understanding of the voice (Howard et al., 2015). Both in vivo and ex vivo animal studies have
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been performed, each with their individual advantages. In vivo models provide physiologic
activation of the intrinsic muscles of the larynx, where ex vivo models use a simulated approach
for muscle contraction and relaxation (Birk et al., 2017).
In general, animal models involving pig, dog, cow, and rabbit larynges have been
extensively studied in attempt to better understand the human voice and laryngeal pathologies
(Maytag et al., 2013). Each of these animals have benefits in studying the human voice; but pig,
dog, and cow histological laryngeal composition differs notably from the human histological
structures, making the translation to human research on vocal fold layers and histology
questionable. Maytag et al. (2013) proposed that rabbit larynges are the most accurate model to
study the human voice due to similar tissue composition. Humans have three layers of lamina
propria, each composed of different fibers. Human vocal folds have a superficial layer of loose,
pliable, gelatin like substance, an intermediate layer of dense ground substance and elastin, and a
deep layer of collagen. In most animals, the composition of the lamina propria layers differ. In
rabbits, however, the composition is the same, making them a more ideal model for
understanding the human voice and the potential effects medications may have on the vocal fold
tissue (Maytag et al., 2013). Using rabbits to study the effects of ICs on the voice provides an
opportunity to reliably quantify vocal fold vibrations and aerodynamic measures (Maytag et al.,
2013). In addition to their having similar tissue properties, the rabbit is small and ideal for in
vivo drug administration.
In 1993, Jiang and Titze established a benchtop setup to study ex vivo larynges. The
model established by Jiang and Titze (1993) has been repeatedly used by researchers in the field
to study a variety of aspects of the human voice. Maytag et al. (2013) reported a modified
benchtop setup for studying ex vivo rabbit larynges. Benchtop setups allow research to be
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conducted on a variety of measurements that may be used to compare animal phonation to voice
production in humans. Ex vivo models provide a reliable alternative to in vivo experiments when
using the benchtop setup. In comparison to in vivo, ex vivo experiments require static and manual
control of the larynx via sutures or screws, whereas in vivo utilizes a complex connection of
muscle contractions and movement of cartilages (Birk et al., 2017). Using a benchtop,
researchers have found that they can manually apply force to the thyroid cartilage via sutures to
provide a simulation of cricothyroid muscle contraction. Adduction is achieved in ex vivo
larynges by applying force laterally to the arytenoid cartilage, simulating the lateral cricothyroid
muscle movement (Birk et al., 2017). The benchtop setup has been well researched and adapted
to make it as reliable as possible for translating to in vivo and human voice research.
Additionally, the benchtop setup proposed by Jiang and Titze (1993) provides a way to simulate
different voice disorders to effectively study the nature and characteristics of the voice without
relying on human subjects (Birk et al., 2017; Döllinger et al., 2018; Hottinger et al., 2007).
Benchtop Measures of Voice Function
Aerodynamic and acoustic parameters as well as high speed imaging are frequently used
to examine voice production. The acoustic signal is typically used in benchtop work to inform
aerodynamic measures as it represents the vocal sound source but not the source-filter
interactions. Phonation threshold pressure (PTP) and phonation threshold flow (PTF) are two
aerodynamic measures that have recently been used in combination to provide insight into the
effort required to initiate vocal fold oscillation, or phonation onset (Hoffman et al., 2012; Jiang et
al., 1999).
The aerodynamic measure most routinely used in benchtop work is PTP, measured in cm
H2O (Jiang et al., 1999). Phonation threshold pressure (PTP) is defined as the minimum
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subglottic pressure needed to initiate and sustain phonation (Jiang et al., 1999). Phonation
threshold pressure has been used for many years to quantify disorders caused by vocal fold
swelling and masses (Jiang et al., 1999) and has advantages of longstanding translational use that
can be compared to humans. To measure PTP, direct or indirect measures can be taken. Three
methods of directly measuring PTP including a translaryngeal catheter inserted through the nasal
passageway down into the trachea passing through anesthetized vocal folds, a percutaneous
catheter inserted into the trachea, and an intraesophageal catheter swallowed in a small balloon
(Plexico et al., 2011; Plant, 2005; Plant et al., 2004). Measuring PTP directly has been done for a
number of years, but it is very invasive in nature. Hence, direct measurements are not generally
used in clinical settings.
To facilitate the use of PTP as one measurement of voice function, indirect measurements
were developed that are noninvasive and which can be used clinically. The common indirect
approach is to measure intraoral pressure while having the speaker produce a string of voiceless
bilabial stop consonants (Smitheran & Hixon, 1981). When using the indirect measure,
subglottic pressure is equal to the intraoral pressure at the initial point of lip separation (Plant,
2005). An advantage of studying an ex vivo larynx on the benchtop model is that PTP can be
measured directly by applying a pressure sensor directly below the vocal folds, making it an
accurate measurement and not just an estimate (Birk et al., 2017).
Phonation threshold pressure has been established as a valuable aerodynamic measure for
many years and is used in the assessment of vocal fold pathologies (Hottinger et al., 2007; Jiang
et al., 1999; Plant, 2005). Jiang et al. (1999) found statistical differences in PTP when evaluating
individuals with vocal fold polyps compared to individuals with normal, healthy voices. Studies
have shown that when there is an increase in vocal fold mass, caused by growths or swelling,
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PTP will rise (Jiang et al., 1999). In general, there are four contributing factors to PTP values.
These factors are 1) vocal fold viscosity, 2) velocity of the mucosal wave, 3) prephonatory
glottal width, and 4) vocal fold thickness (Jiang & Titze, 1993; Plexico et al., 2011). An increase
in vocal fold viscosity will increase PTP, a primary reason why vocal fold hydration is a key
factor in maintaining a healthy voice (Plexico et al., 2011). There are many other physiological
or biomechanical changes that can occur to the vocal folds due to vocal trauma or laryngeal
pathologies, all of which change PTP in a predictable manner (Plexico et al., 2011).
In 2007, PTF was introduced as an additional aerodynamic measure to evaluate the voice
(Jiang & Tao, 2007). PTF, measured as mL/s, is defined as the minimum amount of airflow to
initiate stable phonation (Jiang & Tao, 2007). Similar to PTP, PTF is dependent on glottal
configuration, tissue properties, and vocal tract loading (Jiang & Tao, 2007). In contrast to PTP,
PTF has been shown to be more sensitive to changes in glottal width, leading some researchers
to suggesting PTF is more clinically valuable than PTP (Hottinger et al., 2007). PTF is measured
noninvasively by averaging the glottal flow rate during vowel production (Jiang & Tao, 2007).
PTP and PTF have different diagnostic advantages but are both valuable aerodynamic
measures. Pressure and flow can be measured at onset, during sustained phonation, and at the
offset of phonation, with sustained and offset pressure being measured through tracheal puncture.
The measures of PTP and PTF are specific to phonation onset. Subglottic air pressure is the key
driving force for airflow through the larynx and both play a key role in phonation (Plant, 2005;
Plant et al., 2004). Threshold values can be influenced by a number of factors including
fundamental frequency (F0), vocal intensity, and laryngeal resistance (Plant et al., 2004).
Abnormal changes in aerodynamic functions often indicate vocal fold pathologies and provide
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diagnostic information regarding speech system dysfunctions, which has clinical significance
(Hoffman et al., 2012; Hottinger et al., 2007; Jiang & Tao, 2007).
Context for Current Study
This thesis is part of a larger study being completed under Dr. Kristine Tanner with the
long-term goal to prevent and cure voice disorders caused by IC treatment. The study examines
the adverse effects of inhaled corticosteroids on the vocal folds and it aims to quantify threshold
for voice function changes associated with ICs.
Statement of Purpose
The purpose of this study is to quantify aerodynamic measures of PTP and PTF in rabbit
vocal folds treated with IC. Asthma prevalence is increasing by 10% each decade, with ICs
becoming the treatment of choice. The increase in prevalence and administration of ICs has
resulted in an increase of voice disorders caused by IC treatment in up to 50% of individuals
with asthma (Galván & Guarderas, 2012; Williamson et al., 1995).
In any study, a control group is necessary to know what changes occur in the
experimental group. In many voice studies nebulized isotonic saline is used as the control
treatment. In a study completed by Tanner et al. (2015), it was found that nebulized saline (0.9%
Na+Cl-) improved voice production in individuals with Sjögren Syndrome, an autoimmune
disease-causing vocal fold dehydration. An additional study completed by Welham et al. (2009)
compared vocal fold scar healing in a treatment, sham, and control group. The sham group was
treated with saline, while the control group received no treatment. Results of this study indicate
that PTP, glottal resistance, and glottal efficiency were of similar values in the sham group and
the control group, indicating reliability in using saline as a sham and/or control group for future
studies.
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Research Questions
Based on the extant literature, it was hypothesized that IC usage would cause adverse
effects on voice function in an excised larynx model. Specifically, it was hypothesized that
rabbits that received IC treatment over time would have higher (i.e., worse) airflow
characteristics as measured using PTP and PTF as compared to controls. This study will address
the following research questions:
1. What are the onset pressure and airflow characteristics of rabbit vocal folds following
eight-week exposure to inhaled corticosteroids?
2. How do these onset pressure and airflow characteristics differ from control rabbit
vocal folds exposed to inhaled saline?
Method
This thesis was part of a larger series of studies being conducted by Kristine Tanner,
PhD, Associate Professor in the Department of Communication Disorders at Brigham Young
University (BYU). The larger project was funded by the National Institute on Deafness and
Other Communication Disorders at the National Institutes of Health. This thesis included a
between-groups experimental design, with two groups of rabbit larynges having been exposed to
either ICs or nebulized isotonic saline two times each day for eight weeks at The University of
Utah. For this study, the independent variable was group (i.e., IC versus saline); the dependent
variables were two aerodynamic measures at the onset of phonation using a benchtop
experimental setup, namely PTP (cmH2O) and PTF (L/min).
Statement of Research Ethics
All data collection and analysis procedures complied with research ethics for animal
research. The Institutional Animal Care and Use Committee approved the project procedures at
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both The University of Utah and BYU. The thesis methods were also compliant with BYU Risk
Management policies.
Larynx Samples
Pre-Study Treatment Administration
The larynges for this thesis were obtained after all living animal procedures were
completed. Preparation for this study was as follows. At The University of Utah, 22 male, white
New Zealand retired breeder rabbits, ages seven to eight months, were obtained. Each rabbit
weighed between 3.1 and 4.8 kg prior to quarantine. Randomization of rabbits was performed
using a random number generator and 11 rabbits were assigned to each group. For the IC group,
rabbits were administered one puff of fluticasone propionate (45 mcg) and salmeterol (21 mcg)
from a metered dose inhaler with spacer (i.e., an animal “puffer” with facemask) twice daily. The
animals inhaled the ICs transnasally for 18 breaths. The 11 control rabbits received aerosolized
saline solution twice daily, 18 transnasal breaths per administration, using an ultrasonic nebulizer
and facemask. During the administration, the rabbits were awake and carefully handled using
standard procedures. After receiving treatment for 8 weeks, the rabbits were euthanized.
Immediately after euthanizing, a vertical incision was made on the anterior portion of the neck to
expose the trachea and larynx after which the neck opening was maintained using metal
hemostats and a fine scalpel was used to dissect away neck musculature. Tissue was dissected
until the superior border of the thyroid cartilage and the inferior border of the trachea were
exposed. Excision of the full length of the trachea, false vocal folds, true vocal folds, epiglottis,
arytenoid cartilage, and the thyroid cartilage was performed. Once extracted, the larynges were
placed in small vertical plastic tubes in phosphate-buffered saline (PBS) solution. The tubes were
then placed in a tray of isopropyl alcohol to prevent ice crystals forming while flash freezing in
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liquid nitrogen. Larynges were stored at -80°C in a research lab at The University of Utah until
ready for transportation to BYU for data collection.
Larynx Procurement
Larynges were transported to BYU by the thesis study team in a foam cooler to room 105
of the John Taylor Building Annex where they were stored. The larynges were placed in a
ThermoScientific Freezer at -80°C for approximately 12 to 15 hours before data collection. Upon
completion of all thesis data collection, samples were returned to The University of Utah.
Fine Dissection
On the day of data collection, each larynx was removed from the freezer and placed in a
lukewarm bath to thaw approximately 30 minutes before trials were to be run. Once fully
thawed, the larynges were removed from the PBS solution and finely dissected using X-ActoTM
knives, scalpels, and small surgical scissors. Throughout the dissection process, larynges were
kept hydrated by dipping them into PBS solution and spraying them with a 0.9% isotonic saline
(Na+Cl-). Figure 1 is a photo of larynges in their PBS containers during the thawing process.
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Figure 1
Thawing Larynges Prior to Fine Dissection

The trachea was transected, leaving approximately 2 cm to facilitate optimal stabilization
on the benchtop set up. The epiglottis and superior portion of the thyroid cartilage above the
thyroid notch were dissected. The false vocal folds were dissected along with any excess tissue
to reveal the true vocal folds. Hemostats were used to hold tissue in place and provided more
accurate dissection. Once finely dissected, a surgical suture was threaded above the anterior
commissure to allow for anterior attachment and stability. After dissection, larynges were placed
back into a small tube filled with PBS until ready to be mounted for data collection. Figure 2 is a
photo of a rabbit larynx during the fine dissection process.
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Figure 2
Fine Dissection

Benchtop Setup
The benchtop setup designed by Jiang and Titze (1993) and modified by Maytag et al.
(2013) was used to guide the benchtop setup for this study. A medical-grade air tank provided
compressed air with low humidity (50 psi, <1% relative humidity). The tank was secured to the
wall via chains in accordance with Joint Commission on Accreditation of Healthcare
Organizations and the Occupational Safety and Health Administration standards. Air passed
from the air tank through a respiratory flow head transducer (Model MLT300L, AD Instruments,
Sydney, Australia) to a ThereaHeat heated humidifier (Model RC7000, Smiths Medical, Dublin,
OH). Air was humidified and traveled through tubing connecting to a 20 cm aluminum foam-
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insulated custom pseudo lung attached beneath the breadboard benchtop (Thorlabs, Ann Arbor,
MI). The pseudolung was suspended under the benchtop via benchtop pins and strings. Tubing
protruded up from the pseudolung where two silicone devices designed to taper the airflow and
narrow the passage from the tubing rested on the benchtop. A 10 mL syringe approximately the
average width of rabbit larynges was situated over the two silicone devices and provided a
location for the larynges to be mounted to the benchtop.
On the surface of the breadboard, three adjustable single prong micropositioners were
mounted on the benchtop used to stabilize the larynx and adduct the vocal folds. Two
micropositioners were placed lateral to the syringe head and one was placed anterior. The
anterior micropositioner provided a location for the string attached to the thyroid via suture in the
thyroid cartilage to attach. A subtracheal outlet was drilled into the tubing directly above the
benchtop where a physiological pressure transducer (Model MLT844, AD Instruments, Sydney,
Australia) attached perpendicular via a stop cock to the upward vertical airflow. A microphone
was placed approximately 10 cm at a 45° above the mounted larynx to collect acoustic data. A
digital hygrometer was used to monitor and report room temperature and humidity during data
collection. Figure 3 is a photo of the benchtop setup and its components.
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Figure 3
Benchtop Setup

Acquisition System Calibration
Prior to running trials, pressure and flow were zeroed and calibrated using LabChart™
version 8 (PowerLab ™, AD Instruments, Colorado Springs, CO). The respiratory flow head was
attached to a Glottal EnterpriseTM pneumotach calibration unit to sample the airflow in L/min.
The flow was then calibrated to 1 L/min. The pressure transducer was calibrated by the
PowerLab ™ system to 40 mmHg.
Mounting the Larynx
When ready to run trials, a finely dissected larynx was mounted on the syringe head on
the benchtop setup. The trachea was secured on the setup using Zip TiesTM and Teflon ™ tape if
needed to prevent air leakage. The two lateral micropositioners were inserted into the arytenoid
cartilage at equal levels to stabilize the larynx and adduct the vocal folds. The suture thread in
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the anterior commissure of the thyroid was tied to the anterior micropositioner to stabilize the
larynx. The micropositioner was tightened just enough to stabilize but not to lengthen the vocal
folds. Figures 4 illustrates the mounted rabbit larynx and three micropositioners; Figure 5 is a
close-up photo of the mounted larynx.
Figure 4
Larynx and Micropositioners
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Figure 5
Close-Up of Benchtop Mount

Data Collection
Once mounted, 15 phonatory trials were run on each rabbit larynx. Air was supplied from
the compressed air tank and gradually turned on by twisting a knob until phonation began. Air
passed from the air tank, through the tubing and humidifier, up the pseudolung and syringe tip to
vibrate the vocal folds. Once phonation was initiated, the air flow was held at a constant state for
approximately 3 seconds and then turned off. During each trial, the acoustic signal, pressure, and
flow were acquired. During all 15 trials the micropositioners and position of the larynx remained
stable. Pressure was measured by the pressure transducer prior to air reaching the vocal folds and
flow was measured by the flow meter. Tissue was kept hydrated throughout the 15 phonatory
trials by spraying 0.9% saline solution every two to three trials as needed.
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Data Analysis
After collecting data, using a previously established methodology (Prigmore, 2020),
markers were placed at phonation onset, steady state, and offset for each trial. The signals were
the averaged within 10 ms of phonation onset. Phonation onset was determined acoustically and
visually by listening to acoustic signals and analyzing recurring oscillations in the acoustic
signal. Analysis was performed using a custom Matlab program (MathWorks, Natick, MA)
written by Christopher Dromey, PhD, who is a member of this Thesis Committee. Phonation was
analyzed for each phonatory trial using Praat, version 6.0.49 (Boersma & Weenink, 2020).
Statistical Analysis
For purposes of the parent project, summary data for onset and sustained pressure,
airflow, laryngeal resistance, and F0 were examined. Data distributions were examined visually
using box plots. One-way analysis of variance was conducted for each of these variables. For this
thesis, Student Newman-Keuls analyses were conducted for PTP and PTF using an alpha level of
.05. Analyses were conducted using the Statistical Analysis System (version 9.4, Cary, NC) by
Ray M. Merrill, PhD, in Life Sciences at BYU.
Results
As described in the Method section of this document, several analyses were undertaken to
address the proposed experimental questions. First, descriptive characteristics of the laryngeal
specimens and environmental conditions in this study are provided. Second, descriptive statistics
for PTP and PTF values are included. Lastly, this investigation’s experimental hypotheses are
examined using parametric statistics as described below. Of note, one control group specimen
was excluded from all analyses due to structural damage to the larynx that resulted in the
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inability to properly mount and elicit phonation. Therefore, the final data set included 11
larynges in the inhaler group and 10 in the control group.
Specimen and Environment Data
Measurements were taken using a digital caliper for information regarding tracheal,
laryngeal, and vocal fold dimensions. Tables 1, 2 and 3 include precise measurements of each
rabbit larynx used in the study reported in mm. Each of these measurements supports a thorough
representation of the size of each specimen in this study and for comparison and replication
purposes in other investigations.
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Table 1
Anatomical Tracheal Dimensions
Group

Trachea length (mm)

Trachea width (mm)

1

12.52

7.15

2

14.52

5.81

3

14.10

5.80

4

15.84

6.08

5

12.32

5.64

6

16.54

8.20

7

14.35

6.03

8

19.10

7.18

9

13.18

6.75

10

13.68

7.16

11

14.56

6.08

1

15.15

6.64

2

19.53

7.04

3

18.89

5.5

4

16.24

7.16

5

18.10

6.94

6

16.00

7.09

7

17.40

5.96

8

15.47

7.28

9

15.32

7.28

10

12.56

7.75

Inhaler

Control
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Table 2
Vocal Fold Anatomical Size and Dimensions
Group

Length of vocal folds

Width of vocal folds

Width from vocal fold to

(mm)

(mm)

thyroid cartilage (mm)

1

5.73

1.10

3.58

2

6.37

1.88

2.78

3

6.65

1.56

3.30

4

6.51

1.70

3.29

5

6.37

1.68

3.65

6

5.87

1.62

2.51

7

6.82

1.61

3.64

8

7.88

1.73

2.78

9

7.33

1.73

2.78

10

6.59

1.34

3.58

11

7.63

2.00

3.76

1

6.48

1.44

3.82

2

6.62

1.61

3.76

3

6.69

2.10

3.15

4

7.15

1.84

3.53

5

7.31

1.65

2.85

6

6.44

1.59

3.73

7

7.07

1.76

3.43

8

7.03

2.03

3.23

9

5.77

1.72

3.01

10

6.68

1.85

3.42

Inhaler

Control
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Table 3
Thyroid Cartilage Anatomical Measurements
Group

Protuberance to bottom (mm)

Width (mm)

1

3.35

13.81

2

2.44

13.75

3

2.44

13.75

4

1.77

12.93

5

2.04

12.82

6

4.32

12.85

7

3.82

13.47

8

2.80

14.19

9

4.81

14.32

10

4.75

14.02

11

3.98

12.51

1

2.71

13.81

2

2.93

13.45

3

3.54

14.46

4

4.58

14.39

5

3.66

13.72

6

3.80

15.76

7

4.38

15.11

8

4.92

15.14

9

3.78

13.52

10

5.54

14.22

Inhaler

Control

For each data collection session, both room temperature and environmental humidity
levels were recorded. Specifically, baseline and any changes in temperature were tracked.
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Additionally, percent relative humidity was documented at baseline and at the conclusion of data
collection for each laryngeal specimen. These data are provided in Table 4.
Table 4
Room Temperature and Humidity
Group

Session
Date

Initial
Humidity

Final
Humidity

Initial Temperature
(°F)

Final
Temperature
(°F)

Inhaler
1

9/27/2020* 35%

35%

75

75

2

9/27/2019

38%

38%

75

75

3

9/27/2019

37%

37%

75

77

4

9/27/2019

37%

39%

75

75

5

9/27/2019* 36%

36%

75

76

6

10/11/2019 12%

14%

80

80

7

10/11/2019 12%

12%

80

80

8

10/11/2019 12%

15%

78

80

9

10/11/2019 11%

14%

79

80

10

10/11/2019 12%

13%

80

80

11

10/11/2019 14%

14%

80

80

1

1/10/2020

22%

24%

75

76

2

1/10/2020

22%

21%

75

75

3

1/10/2020

19%

21%

75

75

4

1/10/2020

19%

20%

76

76

5

1/24/2020

19%

20%

79

80

6

1/24/2020* 19%

20%

79

79

7

1/24/2020

21%

23%

79

79

8

1/24/2020

23%

22%

80

79

9

1/24/2020

20%

23%

79

80

10

1/24/2020

23%

23%

79

79

Control

Note. *Replaced by approximates based on series of rabbits and time-frame comparisons.
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Descriptive Statistics
Descriptive statistics for PTP and PTF were generated for both the experimental (inhaler)
and control (saline) groups. The mean PTP for the experimental group was 7.82 cmH2O (SD =
2.58; Range = 5.18-11.84); mean PTP for the control group was 7.44 cmH2O (SD = 1.67; Range
= 5.18-10.94). Regression line analysis for PTP in the experimental and control group is shown
in Figure 6. The mean PTF for the experimental group was 0.10 L/min (SD = 0.04; Range =
0.05-0.18); mean PTF for the control group was 0.07 L/min (SD = 0.03; Range = 0.02-0.12).
Regression line analysis of PTF in the experimental and control group is shown in Figure 7.
Average F0 for the inhaler group was 519.85 Hz (SD=66.61); average F0 for the control group
was 446.91 Hz (SD=130.63). Visual inspection of PTP and PTF outcome data using box plots
and distribution examination were compatible with the assumptions for parametric analysis of
variance.
Figure 6
Regression Line Analysis for PTP Inhaler and Control Group

Control:

Inhaler:
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Figure 7
Regression Line Analysis for PTF Inhaler and Control Group

Control:

Inhaler:

Group Comparisons
A repeated measures one-way analysis of variance (ANOVA) was undertaken to examine
the effect of inhaler use on PTP. The results indicated that inhaler use significantly influenced
PTP across phonation trials for both groups [F(35, 279) = 124.09, p = 0.0001]. A post-hoc
Student-Newman-Keuls analysis indicated that mean PTP for the inhaler group was significantly
different than the mean PTP for the control group, p < .05.
Additionally, a repeated measures one-way ANOVA was undertaken to examine the
effects of inhaler use on PTF. The results indicated that inhaler use significantly influenced PTF
across phonation trials for both groups [F(35, 279) = infty, p = 0.0001]. (Note: an infinity f value
is defined as an f-value that is so large it cannot be estimated but is an indication of high
likelihood of differences among the groups.) A post-hoc Student-Newman-Keuls analysis
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indicated that mean PTF for the inhaler group was significantly different than the mean PTF for
the control group, p < .05.
Segmentation Reliability
Although data reduction and aerodynamic analysis procedures were largely automated
via a custom Matlab program, segmentation in LabChart was required for original identification
of phonation onset. Two investigators with extensive training in segmentation procedures
identified phonation onset for each trial. To ensure accuracy of segmentation prior to automated
Matlab analysis, 10% of samples were re-segmented by each examiner for purposes of intrajudge
reliability. Intrajudge reliability for each variable resulted in Pearson correlations greater than or
equal to .98. Additionally, each examiner re-segmented 10% of inhaler and control samples
originally completed by the other examiner (i.e., interjudge reliability). Interjudge reliability was
calculated using ICC and reported to be greater than or equal to .948. These results indicate
acceptable reliability for the segmentation process.
Results of this study indicate significant differences in PTP and PTF measures in rabbit
vocal folds treated with ICs over 8 weeks as compared to rabbit vocal folds treated with
nebulized isotonic saline solution.
Discussion
The current study sought to measure the effects of ICs on aerodynamic measures of the
voice. The purpose of this research was to quantify aerodynamic changes in the voice due to ICs
treatment as there has been an increase in voice disorders caused by ICs in recent years. Rabbits
treated with ICs for 8 weeks were compared to rabbits treated with nebulized isotonic saline
solution. The independent variable was group (IC versus saline) while the dependent variable
were PTP (cmH2O) and PTF (L/min). The primary questions of this study were 1) what are the
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onset pressure and flow characteristics of rabbit vocal folds following 8-week exposure to
inhaled corticosteroids and 2) how do these onset pressure and airflow characteristics differ from
control rabbit vocal folds exposed to inhaled saline? In collecting data, a benchtop setup was
used. Operational procedures remained consistent throughout each dissection, trial, and analysis
using current research on benchtop setups to optimize the results of the study. As hypothesized,
analysis of the data showed significant differences between PTP and PTF in the inhaler and
experimental group.
PTP and PTF Characteristics
Aerodynamic measurements of voice (i.e., PTP and PTF) are frequently used to examine
vocal fold health due to ability to reflect differences in voice productions that can arise from a
variety of factors (Hoffman et al., 2012; Jiang et al., 1999). The minimum amount of subglottal
pressure and airflow needed to initiate phonation is defined respectively as PTP and PTF.
Extensive research has been completed on how to interpret PTP values regarding vocal fold
health. Researchers have found that when PTP increases it is commonly due to growths or
swelling of the vocal fold, specifically in changes to vocal fold viscosity, velocity of the mucosal
wave, prephonatory glottal width, and/or vocal fold thickness (Jiang & Titze, 1993; Plexico et
al., 2011). Results of this study indicate higher PTP values in vocal folds treated with ICs as
compared to vocal folds treated with nebulized isotonic saline. Onset pressure characteristics of
rabbit vocal folds following 8-week ICs treatment revealed a rise in PTP, standard deviation was
higher, and on average the range of values increased, showing greater variability in PTP values
when treated with ICs. Likewise, while PTF is a relatively new measurement, it has been found
that when PTF increases it is commonly due to changes in glottal width due to glottal
configuration, tissue properties, and vocal tract loading (Jiang & Tao, 2007). The results of this
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study revealed PTF values in rabbit vocal folds treated with ICs to have higher PTF on average
with a larger standard deviation and range.
It might be hypothesized that the increase in PTP and PTF values in rabbit vocal folds
treated with ICs over 8 weeks is due to histological changes of the vocal folds. The purpose of IC
treatment is to decrease chronic inflammation of the airways caused by asthma. While ICs are
effective in decreasing inflammation in the lower airway, local upper airway––and specifically
laryngeal––side effects such as dysphonia can occur. These laryngeal changes may be
characterized by laryngitis and hoarseness in a majority of individuals who use ICs. It has been
reported that ICs may cause the vocal folds to swell, leading to increased mass and histological
changes to the vocal folds (Ihre et al., 2004; Hassen & Hasseba, 2016; Sahrawat et al., 2014).
The results of this study are compatible with the literature, indicating that ICs increase the mass
and stiffness of the vocal folds, therefore increasing PTP and PTF and producing a negative
impact on phonation.
Central Tendency and Acoustic Differences Between Groups
It is notable that the inhaler group had a greater standard deviation than the control group.
Greater variation among rabbits in the inhaler group for PTP and PTF is similar to the variation
that is observed among individuals with certain types of voice disorders. It is logical to presume
that individuals with voice disorders associated with ICs would vary in their clinical presentation
and voice characteristics. Several different voice characteristics and presentations have been
reported in the literature (Barnes, 2002; Bhalla et al., 2008; Dogan et al., 2007; Galván &
Guarderas, 2012; Gallivan et al., 2007). Therefore, the increased standard deviation observed in
the inhaler group as compared with the control group supports the overall generalizability of the
animal model used in this study (Erickson & Sivasankar, 2010; Holmberg et al., 2003).
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In the current study, it was also observed that the inhaler group had a slightly higher F0
on average than the control group. It is anticipated that with increased swelling F0 would be
lower as it has been repeatedly found that as mass increases fundamental frequency decreases;
however, results of this study indicate F0 increased in the inhaler group with an average of
519.85 (SD=66.61) as compared to the control group with an average F0 of 446.91 (SD=130.63).
The increase in F0 may be due to not having thyroarytenoid (TA) muscle contraction on the
benchtop setup as the TA muscle is primarily responsible for lowering pitch. It is anticipated that
TA muscle contraction may play a bigger part in what causes disordered vocal folds to have
lower F0. Additionally, TA muscle contraction has been found to be a key factor in individuals
with voice disorders including hoarseness (Chhetri & Neubauer, 2015).
Relationship Between PTP and PTF
Phonation occurs when there is enough pressure (PTP) and flow (PTF) for the vocal folds
to vibrate. A number of theories and laws govern this principle and provide further
understanding of the physiology of phonation. Specifically, the Bernoulli Effect provides clarity
on the relationship between pressure and flow when it comes to phonation. According to
Bernoulli’s effect, velocity of airflow increases as it travels through narrowing vocal folds, upon
which negative pressure causes the vocal folds to be drawn together, closing the glottis. Air
pressure builds up beneath the vocal folds until it reaches a threshold level high enough to
separate the vocal folds. When the pressure is high enough, airflow occurs through the glottis,
separating the vocal folds and releasing air. The separation of the vocal folds occurs until the
myoelastic characteristics of the vocal folds and intrinsic muscles of the larynx take over to draw
the vocal folds back together. This process of drawing the vocal folds together, building up
pressure, increasing velocity, decrease in pressure, and drawing the folds back together is
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repeated to create phonation. Each cycle produces a single pulse of air and when combined
produces phonation (Seikel et al., 2010).
The amount of pressure needed to initiation phonation is PTP, one of the primary
measures of this study. Similarly, the amount of flow needed to initiation phonation is PTF.
Pressure and flow are related in such a way that pressure drives flow through the glottis. It is
expected that as pressure increases flow will also increase if resistance stays constant. This study
found consistent results as both PTP and PTF increased on average compared to the control
group.
Translation Potential to Human Subjects
The goal of this study was to quantify aerodynamic changes in the voice due to ICs usage
to take further steps to understanding changes in the human voice due to ICs usage. In translating
this study to humans, it has been found that rabbit vocal folds a valid model of human vocal
folds due to similar tissue composition. Using rabbit vocal folds, this study was able to
independently examine how possible changes to vocal fold tissue composition changes
phonation. As the layers of the vocal folds change, the nature of vocal fold vibration will also
change. In this study, it was hypothesized that vocal folds swell due to ICs usage, therefore
pressure and flow measurements would be adversely impacted. With an increase in mass of the
vocal folds, higher pressure and flow is required to initiate phonation. This pattern found in the
rabbit larynges can be hypothesized to be identical to how human vocal folds would react to ICs
usage considering the similar tissue composition.
Limitations
Despite best efforts of the researchers, there are limitations to this study. Using rabbit
vocal folds as a model for human voice production has been found to be reliable due to similar
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tissue composition; however, the quiet nature of rabbits may be a limiting factor. When
translating the results to human models, there are many additional factors that influence the
health of the vocal folds including voice usage and intensity of phonation. This study aimed at
identifying only aerodynamic measures; therefore, isolating this measure was effective in rabbit
vocal folds.
The benchtop setup established by Jiang and Titze (1993) was utilized in this study;
however, in order to use the benchtop setup fine dissection of excess tissue was completed to
reveal the true vocal folds. Despite best efforts, human error in dissection is a limitation. Using
knowledge from classes, training from other lab members, and researching additional
information, lab members attempted to consistently dissect equal amount of tissue for each
larynx. Due to human error, some larynges may have had more or less tissue, possibly adversely
impacting measurements. Additionally, while using the benchtop setup, a small microphone was
used to collect acoustic data. During the trials, the microphone was frequently repositioned in
hopes of optimizing the acoustic signal. Because of moving the microphone, acoustic signal
could be different for larynges worked on different days. Only male rabbits were included in this
study. While this was an effective way of controlling experimental factors, it is unknown if
results would be similar in female rabbits. Female rabbits were not included due to prominent fat
deposits that can obscure laryngeal view.
Despite these and other limitations such as small sample size and general methodological
constraints with benchtop models, this study represents an important initial step toward
understanding how voice function is affected by IC use.
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Implications for Future Research
This study provides a foundation for future work regarding the effects of ICs on the
voice. This study showed that there is a significant difference in aerodynamic measures when
using rabbit models to study the voice. Future studies may utilize additional animal and human
models to further examine the effects of ICs on the voice. Rabbits are the most valid model;
however, how this translates to human research is still unclear. Therefore, future research could
look at transitioning these results to human models and comparing the differences between
aerodynamic measures in human and rabbit larynges that have been treated with ICs.
In addition to using human models, further research could be completed utilizing rabbit
vocal folds. This study exclusively used data obtained ex vivo. Future studies could further look
at in vivo acoustic parameters of the voice in comparing ICs and inhaled saline solution and well
as videostroboscopy to visualize the health of the vocal folds as they receive treatment. Due to
the limiting factor of rabbit fold vocal intensity, an additional implication for future research
could be to determine the impact of voice usage in combination with ICs has on vocal quality.
The benchtop setup used for this study has been well researched over the years; however,
in the voice lab where trials were run, continued modification of the benchtop setup would be
beneficial. Future studies could specifically look at automating a saline solution hydration
system to have controlled hydration for each larynx and standardizing the location of the
microphone for acoustic signal. Additionally, future studies could look at detailing a protocol
with specific videos/pictures of what tissue to dissect and how much
Because this study is part of a larger, five-step process, future steps of this project that
have been outlined include using an in vivo rabbit model to determine the threshold for and
reversibility of ICs effects on the voice using transnasal videoendoscopy. Measurements will be
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taken at baseline and every 2 weeks during treatments with the purpose of testing to see if the
effects of ICs can be reversed.
Conclusion
Results of this study show there is a significant difference in aerodynamic measures of
PTP and PTF due to ICs usage as compared to a control group. It was found that PTP and PTF
values on average increased with ICs treatment as well as in the standard deviation and range.
The findings of the current study are vital for future research regarding the effects of ICs on the
voice. Quantifying aerodynamic changes at threshold in the voice due to ICs usage allows further
research to be done that can translate to human subject research.
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APPENDIX A
Annotated Bibliography
Phonation threshold pressure has been extensively researched in the voice field; however,
phonation threshold flow is a relatively new measurement. A comprehensive analysis of the
literature regarding PTP, PTF, ICs use, animal models to study the voice, and the benchtop setup
provided relevant information necessary for the current study. This literature review includes
relevant articles pertaining to different aspects of the study.
Bhalla, R. K., Jones, A. S., & Roland, N. J. (2008). Prevalence of pharyngeal and laryngeal
complications in adult asthmatics using inhaled corticosteroids. The Journal of
Laryngology & Otology, 122(10), 1078-1083. doi:10.1017/s0022215107001272
Purpose of the Study: Inhaled corticosteroids have systemic and local side effects.
Systemic side effects have been well reported, however the literature and research on
local side effects is lacking. The purpose of this study was to examine and report on the
prevalence of local side effects resulting from the use of inhaled corticosteroids. It is
essential that researchers understand the prevalence of local side effects so that
therapeutic strategies can be developed to manage the effects and risk factors of ICS
usage.
Method: This study was a questionnaire based observational design. Participants
were recruited from two local general practices using asthma nurse specialists to assist in
selecting participants based on who was currently prescribed ICs. A pilot study of 20
individuals who had symptoms of pharyngolaryngitis due to ICs completed a respiratory
symptom questionnaire. After the pilot study, 190 patients were administered the
questionnaire via mail. Asthma severity was classified as mild, moderate, or severe using
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the British Thoracic Society guidelines for each participant. Areas assessed in the survey
included smoking history, co-morbidities, preventative measures, and side effects of ICs
including hoarseness, voice weakness, voice loss, sore throat, throat irritation, and longstanding cough. Additionally, the number, type, strength, dosing regime, and duration of
ICs use were assessed. Participated recorded their throat discomfort using a. 10-poiont
visual analogue scale.
Results: The survey had a 75.8% response rate, and the majority of the responses
were from patients with mild or moderate asthma who had been using ICS for 1-5 years.
It was found that asthma severity (mild, moderate, or severe) was directly correlated with
a longer duration of ICS use. The mean discomfort score on the 10-point visual analogue
scale was 4.26, with 0 indicating no discomfort and 10 indicating severe discomfort. In
general, side effects from ICS were observed immediately after use or after 3 months.
Results show that the longer an individual used an inhaler, the more susceptible they
were to have dysphonia including weakness of their voice, throat irritation, and
hoarseness. Overall, hoarseness, sore throat, cough, and throat irritation were found to be
more prevalent than the researchers initially expected.
Conclusion: This observational study found that there are both pharyngeal and
laryngeal local side effects caused by using ICs. Some side effects of inhalers use, such
as voice weakness, are directly attributable to the use of corticosteroids. Additionally,
some side effect, such as throat irritation, are a result of using combined corticosteroids
(steroids and non-steroids). It was determined that there is a correlation between ICs use
and local side effects in the oropharynx and larynx.
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Relevance to the Current Work: This study provides evidence of the negative
local side effects associated with the use of ICs in asthma treatment. The current study is
specifically looking at the aerodynamic side effects of using ICs that indicate dysphonia.
Further examining the aerodynamic side effects will expand our understanding of local
side effects and how they manifest.
Birk, V., Döllinger, M., Sutor, A., Berry, D. A., Gedeon, D., Traxdorf, M., Wendler, O., Bohr,
C., & Kniesburges, S. (2017). Automated setup for ex vivo larynx experiments. The
Journal of the Acoustical Society of America, 141(3), 1349–135
https://doi.org/10.1121/1.4976085
Purpose of the Study: The purpose of this study was to minimize the duration of
experimental procedures in ex vivo larynx studies. The researchers aimed to ease the
variation of parameters in experiments so as to minimize the influence of degeneration
and dehydration of the larynx tissue due too extensive experimental time. The possibility
of achieving an automated onset detection was also examined during this study.
Researchers attempted to create a standardized experimental procedure to maximize the
number of experimental conditions implemented in a single larynx in the shortest
possible amount of time. Automating a set up in attempts to minimize dehydration while
still acquiring sufficient data.
Method: A customized, computer-controlled setup was developed for this study
using a time-dependent variation of vocal fold elongation and adduction. Additionally, an
electro-mechanical device was custom developed for positioning the laryngeal cartilage
and mounting the larynx. The ex vivo porcine larynx was mounted on an artificial
stainless-steel trachea with a hold drilled 130mm below the glottis to measure subglottal
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pressure via an XCS-93-5PSISG pressure sensor. To stimulate cricothyroid muscle
contraction, an electro-mechanical setup would apply a defined amount of force on the
thyroid cartilage, tilting it. An additional device was developed to achieve arytenoid
cartilage rotation to adduct the vocal folds.
Results: The results of this study indicate the effectiveness and functionality of
using a computer controlled, standardized setup for ex vivo larynx studies. Acoustic and
subglottal pressure signals were selected in data acquisition and captured at a sampling
rate of 50 kHz for 5 seconds each. The influence of vocal fold elongation and adduction
on phonation were showed by automated onset detection. In addition, the aerodynamic
measurements taken were compared to similar ex vivo larynx experiments to evaluate the
effectiveness and accuracy of the measurements. The automated onset and offset
measurements results were constant for the phonation position of the larynx. Overall, the
results of this study validated the use of the modified setup.
Conclusion: The setup described and researched in this study provides and
automated, standardized method to studying ex vivo larynges. Ex vivo larynx experiments
are in general limited by tissue degeneration and dehydration, therefore, establishing a
mechanism to automate the experimental process with each larynx has proven to be
beneficial and more time effective.
Relevance to the Current Work: This study relates to the current work as it
gives an overview of different factors an ex vivo experiment must control when studying
the glottis. The current study uses ex vivo rabbit larynges, and while it is not an
automated setup as described and researched in this study, arytenoid rotation,
cricothyroid contraction, and airflow are all manually manipulated in the experiment and

44
must be maintained constant. This study provides resources for how to maintain stable
measurements.
Campagnolo, A. M., Tsuji, D. H., Sennes, L. U., Imamura, R., & Saldiva, P. H. N. (2010).
Histologic study of acute vocal fold wound healing after corticosteroid injection in a
rabbit model. Annals of Otology, Rhinology, & Laryngology, 119(2), 133–139.
https://doi.org/10.1177/000348941011900211
Purpose of the Study: The purpose of this study was to evaluate the histological effects
of injecting dexamethasone sodium phosphate (corticosteroid) into the vocal folds and
the effects it had on acute vocal fold wound healing in rabbit larynges after surgically
induced injury.
Method: This study involved 12 New Zealand albino rabbits. Each rabbit
underwent laryngeal microsurgery where a puncture wound was made with a knife in the
upper surface at midpoint of each vocal fold. After the wound was made, 0.1 mL of
dexamethasone sodium phosphate was injected into the left vocal fold and the right vocal
fold served as a control and was not injected. Three days after the injection six of the 12
rabbits were sacrificed, with the remaining six were sacrificed 7 days after the injection.
The histological features of the excised larynges were then studied.
Results: The mean numerical density of cells in the cortico-steroid treated group
was 3.16, the mean in the control group was 2.48. There was no significant difference
between the amount of collagen in the treated vs. the control group vocal folds. The
concentration of collagen fibers in each vocal fold did show significant increased at 7
days in both the treated and the control group. There was a statistically significant
difference in collagen deposition between the treated and the control group, showing
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corticosteroid treatment to reduce quantity of accumulated collagen during wound
healing.
Conclusion: Corticosteroid injection after vocal fold injury reduces collagen
deposits at the site of injury while in the acute state of recovery.
Relevance to Current Work: This study examined vocal fold healing in
response to corticosteroid injection in rabbits. Details regarding changes in the mucosalwave and how that impacts phonation were discussed in this study. The current study also
uses rabbit vocal folds to study vocal fold health and impacts of corticosteroids.
Corticosteroids will be inhaled, however is it hypothesized that changes to the mucosal
wave will occur, leading to changes in phonation.
Erickson, E., & Sivasankar, M. (2010). Evidence for adverse phonatory change following an
inhaled combination treatment. Journal of Speech, Language, and Hearing Research,
53(1), 75-83. doi:10.1044/1092-4388(2009/09-0024
Purpose of the Study: Dysphonia is a common side effect of ICs treatment for asthma.
The purpose of this study was to examine the adverse effects of ICs treatment on PTP and
PPE (perceived phonatory effort). The researchers tested the hypothesis that ICs
treatment would elevate PTP and PPE, but that the sham treatment would not. They also
examined the relationship between PTP and PPE in individuals receiving ICs treatment.
Method: Participants for this study included 14 adults (9 women and 5 men) with
no reported voice or laryngeal problems. Each participant completed the VHI and scored
a mild voice handicap. All participants were taking Advair diskus IC to treatment of their
asthma once or twice daily for at least 4 months. Data collection occurred at the time
participants habitually took their medication to ensure methodological consistency. Each
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participant completed two experimental sessions on consecutive days to get an IC and
sham treatment. Data was collected during both sessions by calculating vocal pitch range,
PTP, PPE, and FVC. Measurements were recorded both before treatment, immediately
after treatment, 1 hr. and 2 hrs. after treatment.
Results: Results indicated that IC treatment did significantly increase PTP while
the shame treatment did not. The increase in PTP lasted for 2 hours following IC
administration. PPE was not significantly affected by either treatment. Weak correlations
appeared between PTP and PPE.
Conclusion: This study concluded that IC treatments can have a direct effect on
phonation by increasing PTP in individuals with asthma. The study examined the
effectiveness of different levels of pitch and determined that when evaluating voice
functions after IC treatment, it is most useful to evaluate pitch at the 80th percent pitch.
The increase in PTP is suspected to be caused by the deposit of up to 75% of the IC on
the vocal fold mucosa.
Relevance to the Current Work: This study provides background information
regarding voice disorders associated with IC treatment. In addition, it lays a foundation
for the reliability of using PTP as a determinant of vocal health differences due to IC
treatment. The current study uses PTP as a primary aerodynamic measure to study the
effects of IC treatment on the voice.
Gallivan, G. J., Gallivan, K. H., & Gallivan, H. K. (2007). Inhaled corticosteroids: Hazardous
effects on voice—an update. Journal of Voice, 21(1), 101-111.
doi:10.1016/j.jvoice.2005.09.003
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Purpose of the Study: The purpose of this study was to provide updates to previously
found results of strobovideolaryngoscopy (SVL) in individuals who complain of
dysphonia due to ICs treatment. The report includes information from the SVL including
mucosal wave symmetry/periodicity, amplitude and magnitude, phase closure, glottic
closure, supraglottic activity, mucosal quality, and closure on/off glottic plane.
Method: Participants of this study included 38 patients diagnosed with bronchial
asthma being treated with ICS and included symptoms of hoarseness and dysphonia.
Each individual completed a comprehensive history and a physical exam prior to being
assessed by SVL. Throughout the study, a total of 81 videolaryngoscopies were
performed, including 73 transoral SVL, and 6 transnasal SVL. Each examination was
then analyzed for phase closure, amplitude, glottic closure, supraglottic activity, mucosal
quality, and closure on/off glottic plane.
Results: Abnormal periodicity of the mucosal wave occurred in 29/38 patients
taking ICs while 63% (50/79) of all SVL examinations were abnormal. Phase closure
varied in the participants and was open to differentiating degrees in 74% (28/38) patients
and 63% (50/79) in all SVL. Examination of glottic closure often revealed more than one
type of abnormal glottic closure (i.e., bowing, anterior glottal gap, hourglass glottis).
Abnormal glottic closure occurred in 63% (24/38) patients using ICs and 59% (47/79) of
all SVL examinations. Abnormalities in the amplitude and magnitude of the mucosal
wave occurred in 50% (19/38) of patients using ICs and 35% (28/79) in all SVL
examinations. Supraglottic hyperactivity occurred in 39% (15/38) patients and 25%
(20/79) of all SVL. Mucosal quality and vocal fold edge abnormalities was recorded in
34% (13/38) of patients using ICs and 34% (27/79) SVL examinations.
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Conclusion: Side effects of ICS are dependent on the type of ICs used, inhalation
device, dosage, frequency of use, particle size, and local effects. This study showed the
fluticasone containing ICS were the most frequently prescribed ICS that leads to voice
hoarseness, SVL abnormalities, and laryngitis.
Relevance to the Current Work: This study highlighted the differences in side
effects of different ICs, with fluticasone containing ICs being the most commonly
prescribed ICs, as well as the most common cause of dysphonia. The current study uses
fluticasone propionate and salmeterol in treatment. This study helps to make clear the
differences between different ICs, and which ICs have the largest effect on the voice.
This validates the administration of fluticasone in the current study.
Galván, C. A., & Guarderas, J. C. (2012). Practical considerations for dysphonia caused by
inhaled corticosteroids. Mayo Clinic Proceedings, 87(9), 901-904
Review Article: The purpose of this article was to review the pertinent literature on the
incidence of dysphonia associated with ICs, the mechanisms of dysphonia, and the
relationship between ICS and dysphonia. It was reported that 5%-58% of individuals who
use ICs experience dysphonia. ICs are associated with a higher risk of dysphonia and the
method of delivering the ICs affects the likelihood of developing dysphonia, therefore it
was concluded that with an individual with dysphonia, clinicians and researchers should
take into consideration if they are using ICS and which method (MDI or powder) they are
using.
Relevance to the Current Work: This article emphasizes the fact that a high
percentage of individuals who use ICs develop some form of dysphonia. This validates
the necessity of the current study.
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Hassen, H. E., & Hasseba, A. M. (2016). Voice evaluation in asthma patients using inhaled
corticosteroids. The Turkish Journal of Ear Nose and Throat, 26(2), 101-108.
Doi:10.5606/kbbihtisas.2016.79740
Purpose of the Study: Dysphonia caused by ICs usage has been studied by many
researchers, however the specific laryngoscopic and vocal findings of individuals using
ICs have not been studied extensively. The purpose of this study was to assess the voice
changes and laryngeal abnormalities in asthmatic patients using ICS.
Method: Participants were recruited from the Phoniatric Clinic of the King Fahd
Hospital Jeddah with a total of 30 patients using ICS treatment for bronchial asthma
recruited. The minimal duration of treatment for inclusion in the study was 4 months. A
protocol of voice evaluations that included an elementary diagnostic procedure, clinical
diagnostic aids, and additional instrumental measurements was completed for each
participant. In the elementary diagnostic procedure, a comprehensive history and
otorhinolaryngological examination was performed. The severity of an individual’s
asthma was assigned using the Global Initiative for Asthma criteria. Additionally, a
speech sample including conversational speech and dialogue were recorded and assessed
by two phoniatricians. Next, a modified GRABS scaled was used to rank the degree of
dysphonia in each subject experienced. Clinical diagnostic aids were performed using a
Videolaryngoscopy, which was analyzed by two phoniatricians examining vocal fold
edema, erythema, bowing, atrophy, irregular edges, interarytenoid thickening, and
supraglottic hyperfunction. Lastly, acoustic analysis was performed where participants
phonated at their natural pitch and loudness levels.
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Results: It was reported that 53% of ICS users experienced dysphonia to some
degree, with 36.7% having mild dysphonia and 16.7% having moderate dysphonia.
Videolaryngoscopy revealed the most typical finding was interearytenoid thickening and
erythema, as both appeared in 56.7% of participants. Other common findings were vocal
fold edema (36.7%), supraglottic hyperfunction (53.3%), and irregular vocal fold edges
(53.3%). Researchers also found that jitter percentages were significantly higher in these
individuals as compared to normal individuals.
Conclusion: Dysphonia was found in 53% of patients. Most of the voice acoustic
parameters were higher than standard values. The most common side effect of inhaled
steroids is dysphonia.
Relevance to the Current Work: This study reports prevalence of dysphonia in
individuals who use ICS. The current work is researching the aerodynamic effects of ICS
usage on the voice and its contribution to dysphonia caused by ICS usage.
Hoffman, M. R., Rieves, A. L., Budde, A. J., Surender, K., Zhang, Y., & Jiang, J. J. (2012).
Phonation instability flow in excised canine larynges. Journal of Voice, 26(3), 280–284.
https://doi.org/10.1016/j.jvoice.2011.03.007
Purpose of the Study: Aerodynamic measures of subglottal pressure, mean flow rate,
and vocal efficiency provide valuable information regarding the functions of the voice.
The purpose of this study was to examine aerodynamic measurements in an atypical,
chaotic voice by measuring phonation instability flow (PIF) and phonation flow range
(PFR). Phonation flow was chosen as the measurement as phonation instability pressure
as it has been shown to be clinically useful in indicting at what point phonation becomes
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unstable. Researchers wanted to provide an additional measurement with clinical validity
to diagnose disordered voices therefore PFR was also included in this study.
Method: Seven canine larynges were excised using protocol established by Jiang
and Titze (1993). Before experimentation, dissection of unnecessary tissue was
performed, and the true vocal folds were exposed. Once properly dissected, the larynx
was mounted on a bench apparatus as specified by Jiang and Titze (1993). In an effort to
simulate the human respiratory system a pseudolung attached to the benchtop was used to
initiate and sustain phonation throughout the trials designed to simulate the human
respiratory system. For each trial, airflow was gradually increased until phonation began,
at which point onset time, pressure, and flow were recorded. Airflow was then increased
to the point where the stable harmonic frequency of the voice was lost and appeared to be
aperiodic and noise-like; this point was marked as the PIP and PIF. Airflow was then
decreased until phonation ceased. Phonation floor range was calculated by subtracting
PTF from PIF. This process was repeated 5 times in three different glottal configurations
(0% elongation and 0 mm posterior glottal gap; 20% elongation and 0 mm posterior
glottal gap; and 20% elongation with 3 mm posterior glottal gap).
Results: Results of the study show that an increase in vocal fold elongation does
not affect PTF, PIF, or PIP, however there is a nearly significant increase in PTP
following elongation. It was shown that increasing glottal abduction significantly
impacted PTP, PIF, and PFR and had near significant impacts on PTF.
Conclusion: Phonation instability flow was a new aerodynamic measurement
presented in this study and it was shown to be sensitive to glottal abduction as predicted.
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It is suggested that using PIF instead of PIP to measure vocal instability may be a simpler
means to quantify aerodynamic functions of the voice.
Relevance to the Current Work: The current study uses PTP and PTF as
primary aerodynamic measures to evaluate the function of the voice. This study relates to
the current work in its use of a similar methodology and benchtop set up for experiments
and data collection.
Hong, S. J., Lee, S. H., Jin, S. M., Kwon, S. Y., Jung, K. Y., Kim, M. K., Park, H., & Lee, K. W.
(2011). Vocal fold wound healing after injection of human adipose-derived stem cells in
a rabbit model. Acta Oto-Laryngologica, 131(11), 1198-1204.
doi:10.3109/00016489.2011.599816
Purpose of the Study: The purpose of this study was to examine the phonological and
morphological qualities of scarred rabbit vocal folds after injection of human adiposederived stem cells, as well as to examine the survival degree of hADSC.
Method: This study involved 12 white New Zealand rabbits that were
anesthetized and injured with a CO2 laser. They were then injected with hADSC in the
left vocal fold and phosphate-buffered saline (PBS) in the right vocal fold. Every 4
weeks a rigid endoscopic exam was performed to document any morphological changes
including surface irregularities, granulation tissue formation, and atrophic changes. After
12 weeks of injection, each rabbit was euthanized and histological changes were
documented including intra-epithelial inflammation, stromal inflammation, perichondral
fibrosis, and collagen deposition. Finally, the tissue was examined for evidence of human
cells.
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Results: There was a variety of surface irregularities found in both the left and
right vocal folds, however there were no significant differences between the two. It was
reported that 2/12 hADSC treatment rabbits and 10/12 control PBS rabbits had
granulations tissue formation 12 weeks after injection. Significantly less granulation
tissue formatted in the treated vocal folds compared to the control group. There were no
significant differences found between the groups in histological changes regarding intraepithelial inflammation and stromal inflammation; however, the right vocal folds injected
with PBS were found to have significantly more collagen deposits and perichondral
fibrosis than hADSC.
Conclusion: The hADSC remained viable after 12 weeks and may prove to be a
more cost-effective alternative to MSC treatment for vocal fold scarring. Furthermore, it
was shown that hADSC improved vocal fold healing and produced less signs of vocal
fold scarring.
Relevance to the Current Work: Both this study and the current study use white
New Zealand rabbits to study the effects of treatments on the vocal folds. This study
looked at the effects of hADSC on vocal fold healing while the current study is looking at
the effects of ICS on vocal fold health. This study adds to the growing body of research
that validates the use of rabbit vocal folds as reliable models for the study of histological
and morphological changes in the vocal folds due to treatment.
Hottinger, D. G., Tao, C., & Jiang, J. J. (2007). Comparing phonation threshold flow and
pressure by abducting excised larynges. The Laryngoscope, 117(9), 1695-1699.
doi:10.1097/MLG.0b013e3180959e38
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Purpose of the Study: Phonation threshold flow has been proposed as an additional
aerodynamic voice measure to PTP. The purpose of this study was to examine the effects
of different glottal widths and abduction on PTP and PTF. Furthermore, this study looked
at the response of PTF to changes in posterior glottal width.
Method: This study examined 10 excised canine larynges that were harvested
immediately post-mortem from animals that had died of natural causes. The larynges
were stored and frozen in a 0.9% saline solution prior to the dissection of the false folds
and portions of the posterior thyroid cartilage. Larynges were then mounted on a pseudolung benchtop apparatus and stabilized by micropositioners. Glottal width was adjusted
from 0.0-4.0 mm by metal shims. Subglottal pressure and airflow were measured for each
glottal width. Data was then analyzed using LabView.
Results: The average airflow for each glottal width was reported. The average air
flow for 0.0 mm was 376 mL/s, 1.0 mm was 415 mL/s, 2.0 mm was 580 mL/s, 3.0 was
867 mL/s, and 4.0 mm was 1,199 mL/s. PTP was also recorded for each glottal width. 0.0
mm was 9.89, 1.0 mm was 9.26, 2.0 mm was 8.75, 3.0 mm was 9.02, and 4.0 mm was
9.71 cm H20. These results indicate that PTF is sensitive to changes in glottal width and
has a linear relationship with glottal width while PTP is not sensitive to changes in glottal
width.
Conclusion: Phonation Threshold Flow is more indicative of vocal fold
pathologies that affect glottal width than PTP, therefore PTF should be used
diagnostically.
Relevance to the Current Work: This study is relevant to the current work as it
uses both PTP and PTF as aerodynamic measures to examine the health of the vocal
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folds. Both measures have indicative potential for different pathologies and this study
confirms that PTF changes indicate a vocal fold pathology that affects glottal width. This
means that an increase in PTF would merit an examination of glottal width.
Ihre, E., Zetterström, O., Ihre, E., & Hammarberg, B. (2004). Voice problems as side effects of
inhaled corticosteroids in asthma patients—A prevalence study. Journal of Voice, 18(3),
403-414. doi:10.1016/j.jvoice.2003.05.003
Purpose of the Study: The purpose of this study was to examine the prevalence of voice
disorders in individuals who use inhaled corticosteroids in Swedish asthma patients. The
three primary questions answered in this study were 1) to what extent do asthma patients
experience voice problems? 2) do certain voice problems appear more frequently than
others? and 3) are voice problems related to age or gender, the dose, certain substances,
the type of asthma, voice-demanding professions, or acid regurgitation?
Method: A pilot study was performed to develop a questionnaire to be given to
patients. Once the questionnaire was developed, it was administered to 3 different
hospitals and the study was administered over a 6-week period. All participants were
diagnosed with asthma. Overall, 80% (280/350) of participants responded and the results
were analyzed.
Results: Results of the questionnaire indicated that there is a significant positive
relationship between inhalation of cortisone and voice problems. The reported problems
were equally significant for both women and men. The degree of asthma, cortisone dose,
and prevalence of acid regurgitation was significantly positively correlated with voice
problems. Among voice problems, throat clearing, and hoarseness were the most
commonly reported problems. Further results indicated that younger individuals with
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asthma had a higher prevalence of voice demanding professions. These individuals
reported a greater extent of voice problems. A greater number of voice problems were
reported in patients with voice demanding professions and who used inhaled
corticosteroids.
Conclusion: Overall, this study agrees with other studies that show that indicate a
positive correlation between voice problems and inhaled corticosteroids. Individuals who
experienced voice disturbances at a greater degree compared to patients with mild asthma
symptoms appeared to suffer more from their asthma. Voice problems increased with
cortison dosage, therefore individuals with more severe asthma typically reported more
voice problems.
Relevance to the Current Work: This study relates to the current work as it
further examines the effects inhaled corticosteroids have on the voice and on quality of
life. The current study is aiming to better diagnose and assess voice problems due to ICS
usage, and this study is helpful in pinpointing areas that are of main concern.
Jiang, J., O'mara, T., Conley, D., & Hanson, D. (1999). Phonation threshold pressure
measurements during phonation by airflow interruption. The Laryngoscope, 109(3), 425–
432. https://doi.org/10.1097/00005537-199903000-00016
Purpose of the Study: The purpose of this study was to determine the range of values
obtainable by noninvasive subglottal pressure measurements. The study also sought to
estimate the differences in PTP between normal vocal folds and individuals with vocal
fold polyps.
Method: Participants in this study included 11 control participants and 13
participants with polyps. Each individual had an airtight mask affixed over their mouth
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and nose and were instructed to produce a sustained /a/ while airflow was directed into a
section of a pipe. Airflow, intramask pressure, and intensity (in dB) was recorded for
each phonation. PTP was then predicted by calculating the difference between an
estimate of subglottic pressure and the vocal tract pressure at the point phonation ceased.
The 11 control participants sustained /a/ at 75, 80, and 85 dB without difficulty. The 13
individuals with polyps sustained phonation at 65, 70, and 75 dB.
Results: The mean PTP measurements for normal voices were 2.38, 2.67, and
2.98 at each dB level. The mean PTP measurement for individuals with vocal fold polyps
was 4.79, 5.85, and 7.37 at each dB level. The differences between means are statistically
significant.
Conclusion: This study attempts to use noninvasive means to measure and
estimate PTP showed statistical significance. The PTP measurements for control subjects
correlate well with additional similar studies measuring PTP. The difference between
polyp PTP and normal subjects PTP was statistically significant with PTP in patients with
vocal fold polyps being significantly higher than that of control subjects.
Relevance to the Current Work: PTP is a main aerodynamic measurement used
in the current study. This study evaluated different ways to measure PTP and showed that
it is a reliable way to quantify vocal fold health, which is a main reason why PTP is being
evaluated in the current study.
Jiang, J. J., Regner, M. F., Tao, C., & Pauls, S. (2008). Phonation threshold flow in elongated
excised larynges. Annals of Otology, Rhinology & Laryngology, 117(7), 548–553.
https://doi.org/10.1177/000348940811700714
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Purpose of the Study: The purpose of this study is to further examine the aerodynamic
measure PTF purposed by Jiang and Chao (2007). Researchers investigated the reliability
and range of PTF measurements on excised canine larynges with controlled elongation.
PTF measurements were compared to PTP measurements to find the similarities and
relationship between the two aerodynamic measures. The physical parameters of the
vocal folds were manipulated to examine how PTF varies with different pathological
conditions. It was hypothesized that PTF and PTP are directly related in ranges during
phonation initiation.
Method: This study included 10 excised canine larynges that were collected and
mounted to a benchtop pseudo-lung apparatus. Three-pronged devices were inserted into
the arytenoid cartilages to stabilize the larynx, and the anterior edge of the thyroid
cartilage was attached to a micrometer via sutures as to manually elongate the vocal
folds. Five trials were performed for each elongation level at increments of +5%
elongation. An Omega airflow meter was connected to the pseudo-respiratory tract to
record airflow and a digital pressure meter was connected below the vocal folds to record
subglottal pressure. During each trail, airflow was gradually increased from 0 L/min up
until phonation was audible and visible on Lab View. Statistical analysis was performed
using SigmaStata 3.0 to determine PTP and PTF.
Results: The mean PTF values were found to be between 101 mL/s and 217
mL/s. At physiologic length (0% elongation), mean PTF was 162 mL/s. Statistically
significant differences in PTF were found at each elongation level. At +5% elongation,
mean PTF was 181.14 mL/s, at +10% elongation it was 233.65 mL/s, and at +15%
elongation it was 313.33 mL/s.
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Conclusion: This study indicates that PTF is dependent on the biomechanical and
physiological properties of the vocal folds. For example, it is made clear in this study that
PTF increases with elongation. PTF is also dependent upon vocal fold tension and
therefore can be considered an accurate aerodynamic diagnostic tool for assessing
laryngeal function.
Relevance to the Current Work: PTF is a primary aerodynamic measure used in
the current study to evaluate vocal fold health and laryngeal function, and this study
makes clear the effectiveness of PTF as a measure
Jiang, J. J., & Tao, C. (2007). The minimum glottal airflow to initiate vocal fold oscillation. The
Journal of the Acoustical Society of America, 121(5), 2873-2881. doi:10.1121/1.2710961
Purpose of the Study: It has been shown that aerodynamic measures can indicate
speech system dysfunction. Subglottal pressure is one parameter that has been
extensively researched. The purpose of this article was to propose PTF as a new
aerodynamic parameter to be used in the assessment of laryngeal pathologies. PTF is
defined as "the minimum glottal airflow required to initiate phonation".
Method: Researchers analyzed the body-cover vocal fold model to research the
relationship between PTF and phonatory system properties. Using a variety of
mathematical equations, researchers investigated properties such as the influence of
glottal configuration, tissue properties, vocal tract loading, and tissue stiffness on PTF.
Results: The results of this study indicate that PTF can be reduced by reducing
glottal area, mucosal wave velocity, tissue viscosity, increasing vertical length of the
glottal duct, reducing the prephonatory convergent angle, or by increasing the
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prephonatory divergent angle. Additionally, it was found that PTF can be useful when
studying vocal fold vibration and energy transformation in the speech system.
Conclusion: Researchers proposed PTF as a sensitive and effective indicator
when assessing the functional efficiency of the laryngeal system. It is concluded that PTF
may be more practical to use in clinical settings than PTP as it is noninvasive and
changes when vocal fold biomechanics change.
Relevance to the Current Work: PTF is a key aerodynamic parameter used in
the current studies research. This study lays the framework for the use of PTF and the
validity of using PTF clinically and in research.
Keir, S., & Page, C. (2008). The rabbit as a model to study asthma and other lung diseases.
Pulmonary Pharmacology & Therapeutics, 21(5), 721-730.
doi:10.1016/j.pupt.2008.01.005
Purpose of the Study: Using the rabbit to study asthma as a model for the human voice
is a relatively new area of research. The purpose of this article was to compare features of
asthma in rabbits to humans.
Method: This study used rabbits immunized with asthma neonatally for the
purpose of comparison with human asthma symptoms. In total, 8 specific areas were
examined in asthmatic rabbits immunized with asthma. These areas included pulmonary
function, airway hyperresponsiveness, antigen-induced airway responses, airway
inflammation, airway nerves, the effects of drugs on allergen-induced airway responses,
airway hyperresponsiveness and airway wall remodeling, and airway smooth muscle in
vitro were compared for human asthma and asthmatic rabbits.
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Results: Asthmatic rabbits exhibit enhanced airway hyperresponsiveness similar
to that of humans. It was found that rabbits had heightened responses to stimuli in the
airway including histamine, methacholine, and adenosine 5’monophosphate. It was also
found that asthmatic, allergic rabbits were sensitive to and responded to similar drugs as
humans with asthma.
Conclusion: The rabbit is a valid and useful model for use in studying asthma
treatment and lung physiology. The many similarities between human and rabbit larynges
make them ideal for use in studying asthma and lung disease.
Relevance to the Current Work: This study compared asthmatic rabbits to
humans with asthma to evaluate the effectiveness of using rabbits as a model to study
asthma and other lung diseases. The current work utilizes rabbits to examine the effects
of inhaled corticosteroids on aerodynamic measures of the voice, and thus the study
provides a framework for understanding the effectiveness of using rabbits as a model for
studying asthma. Furthermore, this study provides evidence that using the rabbit as a
model to study the effectiveness of different treatments for asthma is appropriate, which
is the basis of the current study.
Mau, T., Muhlestein, J., Callahan, S., Weinheimer, K. T., & Chan, R. W. (2011). Phonation
threshold pressure and flow in excised human larynges. The Laryngoscope, 121(8), 17431751. doi:10.1002/lary.21880
Purpose of the Study: The purpose of this study was to evaluate and report PTP and
PTF in excised human larynges so as to determine whether they are sensitive changes to
posterior glottal width. A secondary purpose was to verify the presence of hysteresis in
human vocal fold oscillation ex vivo.
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Method: This study included 9 excised human larynges that were harvested
within 24 hours postmortem. Prior to phonation trials, excess tissue was dissected and the
larynges were mounted on a benchtop setup. 5 phonation trials were administered for
each posterior glottal width (0.5, 1, 2, and 3 mm) in each larynx. Subglottal pressure was
slowly increased by adjusting the pressure regulator until phonation onset was detected.
Effects of glottal area and posterior glottal width were documented.
Results: It was found that PTP and PTF varied more than offset PTP and PTF.
PTP and PTF offset fluctuated significantly less than PTP and PTF onset measures. A
positive correlation was found between PTF onset and posterior glottal width. Intersubject variability was reported for both PTP and PTF. PTF was higher in ex vivo than in
vivo models.
Conclusion: PTP and PTF aerodynamic measurements in excised human
larynges were similar to those reported in excised canine larynges. Offset PTP and PTF
were lower than onset values. Offset values were determined to be more valuable than
onset values.
Relevance to the Current Work: This study provides an analysis of the
aerodynamic measures PTP and PTF in phonation onset and offset. Likewise, the current
study is examining PTP and PTF values in ex vivo rabbit larynges.
Maytag, A. L., Robitaille, M. J., Rieves, A. L., Madsen, J., Smith, B. L., & Jiang, J. J. (2013).
Use of the rabbit larynx in an excised larynx setup. Journal of Voice, 27(1), 24–28.
https://doi.org/10.1016/j.jvoice.2012.08.004
Purpose of the Study: Excised larynges are frequently used for voice research. Canine
larynges are the common model and the methodology setup necessary for canine larynges
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use is well established. This study examined how researchers can modify benchtop setups
so as to be used for rabbit larynges. Researchers aimed to develop a method of obtaining
accurate and reproducible data from rabbit larynges, including protocol for dissection,
excision, and mounting the larynx protocol. An additional purpose of this study was to
develop a way to achieve reliable phonation and collected video and EGG data.
Method: Study subjects included 5 adult New Zealand white rabbit larynges
whose larynges were harvested immediately postmortem for the study. Before use, each
larynx was thawed, and excess tissues was dissected using microscissors. A custom-built
mounting apparatus was designed for this study and each larynx was mounted on a Luer
lock in the center of the apparatus. The arytenoids were adducted by rods, and humidified
air was passed through the larynx to elicit vocal fold vibration. Five trials were collected
for each larynx. A number of variables were measured during the trials including onset
and offset pressure and flow, fundamental frequency, jitter, shimmer, and signal-to-noise
ratio.
Results: Reliable phonation was achieved in each rabbit larynx. Phonation
threshold pressure was recorded at 16.50 ± 1.24 cm H20. Phonation threshold flow was
reported as 4.61 ± 0.41 L/min. The mucosal wave amplitude for the left vocal fold was
3.32 ± 2.35 pixels and 2.92 ± 2.88 pixels for the right vocal fold. The discrepancy’s
found in these values was similar to discrepancies found in canine larynges.
Conclusion: Researchers were able to obtain an accurate method to use rabbits as
excised laryngeal models. The data found in this study was found to be reproduceable
and repeatable in terms of dissection, excision, mounting the larynx, achieving reliable
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phonation, and collecting data. Rabbit larynges were determined to be valuable in
evaluating vocal fold tissue change.
Relevance to the Current Work: This study provided a reliable methodology for
the use of rabbit larynges in ex vivo studies. The current work uses excised rabbit
larynges to study aerodynamic effects of ICs on the voice and uses similar dissection
techniques to those described in this study. Additionally, a similar benchtop model to the
one in this study is used for mounting larynges in the current work.
Mills, R. D., Dodd, K., Ablavsky, A., Devine, E., & Jiang, J. J. (2017). Parameters from the
complete phonatory range of an excised rabbit larynx. Journal of Voice, 31(4), 517.e9517.e17. doi:10.1016/j.jvoice.2016.12.018
Purpose of the Study: Excised larynges are frequently used to study the vocal folds.
Traditionally, canine larynges were used to study vocal fold mechanics and pathologies,
however they are not an ideal model for studying vocal fold histology. Because of the
similarities in histological makeup between human and rabbit vocal folds, it is proposed
that the rabbit will be a more accurate model for the study of histological changes. The
purpose of this study was to make adjustments to a canine excise booth to allow
collection of a complete phonatory range. PTP and phonation instability pressure (PIP)
were measured and aerodynamic, acoustic, and mucosal measurements were taken across
the entire phonatory range using rabbit larynges.
Method: This study included 7 white New Zealand rabbits that were sacrificed
and whose larynges were harvested and stored for use in this study. After dissection, each
larynx was mounted on a modified benchtop setup as specified by Jiang and Titze (1993).
Data was collected over the complete phonation pressure range (PPR), which is the range
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from PTP to PIP. Flow was increased manually from PTP at increments of 0.25 L/min
until PIP was achieved. PIP was estimated using acoustic waveforms and a real-time
spectrogram.
Results: In total, 15 parameters were taken during the study and 12/15 were
found to be significant. These include PFR, PTP, PPR, F0 at PTP, F0 at PIP, F0 range,
SPL at PTP, SPL range, VA at PTP, VA at PIP, and VA range. It was found that PTP
measurements increased as subglottal pressure, fundamental frequency, and sound
pressure levels and elongation were increased.
Conclusion: This study provided a reliable methodology for the study of
phonation parameters of excised rabbit larynges. The results of this study lead the
researchers to believe that the rabbits is a reliable model for the study of tissue
inflammation.
Relevance to the Current Work: The current work examines aerodynamic
measures in excised rabbit larynges that have undergone ICS treatment, which is
suspected to inflame the vocal folds. This study reported phonatory range of excised
rabbit larynges, which we will also be reporting in the current study. In addition, the
current work utilizes a similar benchtop setup that this study reported using.
Plant, R. L. (2005). Aerodynamics of the human larynx during vocal fold vibration. The
Laryngoscope, 115(12), 2087–2100.
https://doi.org/10.1097/01.mlg.0000184324.45040.17
Purpose of the Study: The purpose of this study was to comprehensively examine the
influence of aerodynamics (including sound intensity, fundamental frequency, and
subglottic air pressure) on laryngeal function. This purpose was separated into 3 portions
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1) a multidimensional comparison of the interaction of subglottic pressure, sound
intensity, and fundamental frequency during speech; 2) examining changes during the
glottic cycle in subglottic pressure; and 3) determining PTP and how it depends on other
aerodynamic parameters.
Method: Study participants for this prospective study included 6 healthy
individuals with no history of voice disorders. Each participant phonated /i/ with a vented
face mask over their face. Each participant completed 5 different speaking tasks. The first
task was to speak three tokens with a breathy onset. The second task was to speak three
tokens with a low pitch while increasing sound intensity with each token. The third task
was to speak three tokens at a mid-pitch level while increasing intensity with each token.
The fourth task was to speak three tokens at a high pitch while increasing intensity each
token. The last task was to speak three tokens while gliding from a low to high pitch.
Airflow, electroglottography (EGG), subglottic pressure, and sound signal were measured
during each task. Subglottic pressure was measured directly inserting a 21-gauge needle
in the cricothyroid membrane. Electroglottography was recorded by placing contact
electrodes on both sides of the neck over the thyroid cartilage.
Results: The relationships between different aerodynamic parameters were
reported. It was found that there was a linear relationship between sound intensity and
subglottic pressure for most participants. Rapid variations were found in subglottic
pressuring during each glottic cycle, relating to the opening of the vocal folds at the
beginning of each cycle. It was found that threshold pressure was primarily dependent on
sound intensity and fundamental frequency. Additionally, it was found the PTP was
higher at onset than at offset.
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Conclusion: The researchers in this study conclude that the larynx responded
predictably despite variability found in specific parameters. It was found that the
behavior of the larynx is governed by the physical properties of air and the anatomy of
the vocal tract.
Relevance to the Current Work: Phonation occurs as a result of interactions
between aerodynamics and glottal properties, and researchers must have a thorough
understanding of those parameters. This study provided instructions for measuring
subglottic air pressure, a key aerodynamic parameter in the current work. Additionally,
this study provided foundational information regarding the workings of the larynx and
what to predictably expect when experimenting on aerodynamic properties.
Plant, R. L., Freed, G. L., & Plant, R. E. (2004). Direct measurement of onset and offset
phonation threshold pressure in normal subjects. The Journal of the Acoustical Society of
America, 116(6), 3640–3646. https://doi.org/10.1121/1.1812309
Purpose of the Study: The purpose of this study was to measure onset and offset
pressure in normal subjects with a variety of voicing conditions. Fundamental frequency,
vocal intensity, laryngeal airway resistance, and the maximum of the first derivative of
the electroglottography signal were also measured. The goal of the study was to
determine if there is a relationship between PTP and the four variables measured and to
examine the differences in onset and offset PTP.
Method: Participants recruited for this study were 5 healthy adults age 26-47.
Each individual participated in 5 different voicing segments which were repeated
throughout the study. First, each individual said three tokens with a breathy onset.
Second, three tokens at a low pitch with increasing lower intensities. Third, three tokens
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at a midpitch level while increasing intensity with each token. Fourth, three tokens at a
high pitch also increasing intensity with each token. Fifth, three tokens gliding from low
to high pitch. To collect data, a Roothenbereg-type mask was placed on the participants
face, EGG electrodes were placed on the neck, and a 21-gaugee needle was inserted
through the cricothyroid membrane to measure subglottic pressure. For analysis
purposed, the onset of phonation was defined as the first periodically varying EGG signal
and the point of phonation onset or offset was selected at the peak of the first derivative
of the first or last EGG waveform.
Results: Univariate and multiple linear regression analysis of the relationship
between variables and threshold pressure were performed. It was found that the
relationships between intensity and fundamental frequency had the largest number of
significant relationships. Significant relationships were found between fundamental
frequency and pressure onset or offset. Intensity, airway resistance, and frequency
predicted threshold pressure in 3 different combinations. Results indicated that offset
pressure threshold is lower than onset pressure threshold.
Conclusion: Directly measuring subglottic pressure indicated that fundamental
frequency influences PTP. It was also shown that vocal intensity and laryngeal airway
resistance can influence PTP.
Relevance to the Current Work: This study examined the differences between
onset and offset phonation threshold pressure and the different variables that influence
both. In the current study, onset phonation threshold pressure is used as a primary
aerodynamic measure. This study provides insight into the use of PTP and into the
variables that impact PTP values.
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Regner, M. F., Tao, C., Zhuang, P., & Jiang, J. J. (2008). Onset and offset phonation threshold
flow in excised canine larynges. The Laryngoscope, 118(7), 1313-1317.
doi:10.1097/mlg.0b013e31816e2ec7
Purpose of the Study: It has been found that PTF is a reliable aerodynamic parameter
and has been compared to PTP in clinical usage. Studies have shown that PTF is more
sensitive to posterior glottal width changes and may be more useful in diagnosing
pathological conditions with an incomplete glottal gap. The purpose of this study was to
further explore the usefulness of PTF. This study investigated onset and offset PTF,
specifically examining the hysteresis effect in PTF. Researchers hypothesized that onset
PTF is higher than offset PTF, and that the hysteresis effect of PTF is similar to that seen
in PTP.
Method: An excised larynx benchtop setup developed by Jiang et al. was used
with ten canine larynges. Prior to mounting on the benchtop, each larynx was dissected to
reveal the true vocal folds and reduce dehydration during the trials. Pressure was
measured for each trial directly below the larynx and acoustic data was collected. For
each trial, airflow was slowly increased consistently until phonation was detected, after
which airflow was decreased until phonation offset. Onset PTP and PTF and offset PTP
and PTF were recorded. This process was repeated three times for each elongation level
(5%, 10%, and 15%). Lastly, the mean onset and offset PTF values were calculated for
each elongation length.
Results: The mean onset PTF at 0% was reported as 3.44.14 mL/s, while the
mean offset PTF at 0% was 287.34 mL/s. The mean onset PTF at +5% was 222.78 mL/s,
and at offset was 182.02 mL/s. The mean onset PTF at +10% 363.11 mL/s, and offset
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was 276.57 mL/s. The mean onset PTF at +15% elongation was 505.24 mL/s and offset
was 379.75 mL/s. The mean PTF hysteresis ration was 0.795±0.116. Additionally, mean
onset PTP was found to be greater than mean offset PTP.
Conclusion: It was found that onset PTF was higher than offset PTF, evidence of
the hysteresis effect in PTF. Additionally, it was concluded that offset PTF is sensitive to
changes in posterior glottal width changes, just as onset PTF is. Therefore, offset PTF can
be clinically effective as well.
Relevance to the Current Work: The current work utilizes PTP and PTF to
determine vocal fold health. This study provided theoretical insight to the clinical
usefulness of PTF and into changes PTF is sensitive to. The current work will primarily
look at onset PTF, which makes information ono hysteresis effect in PTF as well as PTP
essential.
Roy, N., Merrill, R. M., Gray, S. D., & Smith, E. M. (2005). Voice disorders in the general
population: Prevalence, risk factors, and occupational impact. The Laryngoscope,
115(11), 1988-1995. doi:10.1097/01.mlg.0000179174.32345.41
Purpose of the Study: Previous studies have reported the prevalence of voice disorders
in the general population; however, teachers were excluded from the general population
reports for comparison purposes. The purpose of this study was to report the prevalence
of voice disorders and variables associated with populations who have an increased risk
of voice disorders, including teachers in the general population.
Method: A sample of the general population was selected from Iowa and Utah to
complete a phone interview for this study. The sample was obtained using a random digit
dialing method allowing researchers to access residential telephone numbers. Participants
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were asked a number of questions to assess symptoms or signs of voice disorders,
consequences of voice disorders, and potential risk factors of voice disorders. Additional
questions were asked regarding the presence and frequency of voice disorder symptoms
and whether they were occupation-related, medical conditions related to voice disorders,
medication use, chemical exposure, degrees of voice-related work disruption, and
sociodemographic characteristics.
Results: A number of results associated with voice disorder prevalence were
reported. Overall, 29.9% of participants reported a lifetime prevalence of voice disorders
with 6.6% reporting current voice disorders. Women and individuals between the age 4059 reported an increase in chronic voice disorders. Additional risk factors included voice
use patterns, voice demands, esophageal reflux, chemical exposures, colds, and sinus
infections. It was found that voice disorders adversely impacted occupation in 4.3% of
participants and 7.2% of participants reported missing work 1 or more days due to voice
problems.
Conclusion: This study provides valuable information regarding the prevalence
of voice disorders and the factors that contribute to an increased risk of developing voice
disorders. This information can be used in prevention of and education on about voice
disorders in high risk populations.
Relevance to the Current Work: This study provides data on the prevalence of
voice disorders in the general public. The current work looks at voice disorders due to
ICs use for asthma treatment. This study provides data on the impact voice disorders have
on one’s occupation, and what individuals with ICS induced dysphonia also struggle
with.
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Roy, N., Merrill, R. M., Thibeault, S., Parsa, R. A., Gray, S. D., & Smith, E. M. (2004).
Prevalence of voice disorders in teachers and the general population. Journal of Speech,
Language, and Hearing Research, 47(2), 281-293. doi:10.1044/1092-4388(2004/023)
Purpose of the Study: The purpose of this study was to determine the prevalence of
voice disorders in age-specific groups of the general population, and more specifically in
teachers. It also examined demographic variables that may contribute to a higher
prevalence of voice disorders.
Method: In total, 2,351 Teachers and nonteachers were surveyed from Utah and
Iowa for this study. Each participant completed a 30-minute phone survey answering a
voice disorders questionnaire.
Results: It was reported that 43% of the total population reported having voice
disorders and 18.6% reported having chronic voice problems, defined as longer than 4
weeks. Additionally, 81.4% reported experiencing acute voice problems, defined as less
than 4 weeks. The prevalence of voice disorders increased with age and was most
common in people 50-59 years old. Teachers reported voice problems significantly more
frequently than nonteachers. Women had a higher prevalence of voice disorders than
men.
Conclusion: The results of this study indicate that a large percentage of the
population will experience acute voice problems at some point in their life, with teachers
being more likely to experience voice disorders than other members of the general
population. In addition, teachers are more likely to report voice disorders. One variable
surveyed was frequency of voice disorders co-occurring with asthma and it was found
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that prevalence of voice disorders was significantly higher in individuals who had
asthma.
Relevance to the Current Work: This study provided information on the
prevalence of voice disorders in the general public and in teachers who are at high risk.
One of the aspects examined was the prevalence of voice disorders cooccurring with
asthma. It was reported that there was a significantly higher likelihood that an individual
with asthma would experience a voice disorder during their lifetime. The current study is
part of a larger research project designed to evaluate the voice disorders that are a result
of ICS use as a treatment for asthma, therefore this study will help to further diagnose
and prevent voice disorders in the general public and in individuals who have high voice
usage jobs.
Sahrawat, R., Robb, M. P., Kirk, R., & Beckert, L. (2014). Effects of inhaled corticosteroids on
voice production in healthy adults. Logopedics Phoniatrics Vocology, 39(3), 108-116.
Purpose of the Study: The purpose of this study was to examine the effects of ICs on
individuals with otherwise healthy voices. It has been noted that often individuals with
asthma experience various comorbidities such as a constant cough, allergies, paranasal
sinus disease, and gastroesophageal reflux; therefore, the exact effects of ICs on the voice
in individuals with asthma has not been studied. This study intends to answer the
questions 1) Does short-term repeated use of ICS result in change in acoustic parameters
of voice production, and 2) is there a sex difference in the effects of ICS on voice
production?
Method: This study included 30 participants (15 male and 15 female) who were
recruited from the University of Canterbury with ages ranging from 18-30 (average age
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of 24). Each participant had no history of speech, voice, or language disorders and was
judged to have normal voice quality by an experienced speech-language pathologist.
Furthermore, none of the participants had a history of asthma or respiratory illness. Over
a period of 6 days, individuals recorded audio samples and received ICS treatment. On
the first day of the study, the individual came in in the morning to audio record the
baseline samples. The audio recording consisted of sustained /i/, /a/, and /u/ for 5 seconds
three times each, as well as reading the 'Rainbow Passage' to obtain a connected speech
sample. After the baseline audio recording, each participant inhaled 500 μg of
corticosteroid, fluticasone propionatee (FP). One hour after inhalation, each participant
made a second audio recording of their voice. In the evening of the first day of the study
the participants received a second round of ICS treatment and one hour after treatment
participated in an additional audio recording. Days 2-4 of the study the participants
received ICS treatment in both the morning and the evening. On day 5 of the study, the
participants received ICS treatment in the morning and evening and recorded an audio
sample in the evening. On day 6, the participants recorded their Pos-ICS audio recording
in the morning. After all audio samples were recorded, acoustic analysis and long-term
spectral analysis were performed to examine vocal fundamental frequency, formant
frequency and formant bandwidth.
Results: Results indicate a short-term detrimental effect on a variety of acoustic
properties of the voice with acoustic parameters returning to normal after ICs treatment
had been discontinued. There was no statistically significant relationship between the
effects of ICs on fundamental frequency. There was a significant difference in F1
between genders, and F1 was significantly lower for /i/ after Is usage. There was a
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significant difference in F2 between genders, but no significant effect due to ICs
treatment. Exposure to ICs had no significant effect of F2 for the three vowels sampled.
The bandwidth analysis indicated no significant effects on BW from exposure to ICS.
The use of ICS did not affect the average vocal fold vibration rate, as indicated by no
significant difference in fundamental frequency. FCS and ST analysis of the connected
speech sample indicate an increase in FSP during the audio recording on the 5th day.
Conclusion: The findings of this study indicate that researchers must have a
tradeoff between using participants who have pre-existing asthma conditions and
participants who have healthy, normal voice functioning. This study controlled for comorbid factors that appear with asthma. Effects of ICs use appeared within one week of
treatment and was most evident in connected speech samples. The changes found in this
study were relatively minor, however they show the immediate impact of ICS on healthy
vocal folds.
Relevance to the Current Work: The effects of ICs is the key component of the
current work. This study examined the effects of ICs on healthy human participants just
as the current study will test the effects of ICs treatment on healthy rabbits. This study
analyzed different acoustic parameters, whereas the current study is mainly focused on
aerodynamic measures; however, it is important to understand all aspects and parameters
to understand the effects ICs can have on the voice.
Swanson, E. R., Abdollahian, D., Ohno, T., Ge, P., Zealear, D. L., & Rousseau, B. (2009).
Characterization of raised phonation in an evoked rabbit phonation model. The
Laryngoscope, 119(7), 1439–1443. https://doi.org/10.1002/lary.20532
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Purpose of the Study: The purpose of this study was to determine if an increase in
airflow rate would change the glottal configuration in rabbit larynges and contribute to an
increase in phonation intensity.
Method: Endoscopic glottal images were collected from 6 New Zealand white
breeder rabbits to document glottal configuration. Acoustic data was also collected and
analyzed for phonation intensity between modal and raised phonation. Each rabbit was
anesthetized for data collection. The neck of the rabbit was shaved and prepped for
surgery and the larynx and trachea were exposed via a midline incision. A cuffed
endotracheal tube was inserted into the upper portion of the trachea with the cuff inflated
to seal off the trachea and ensure flow of air through the glottis. Once the cuff was
inflated, electrodes were inserted into the CT muscle to serve as cathodes and anthodes
for electrical stimulation. Video documentation of glottal positioning and closure was
obtained during phonation and acoustic signals were recorded.
Results: The mean phonatory intensity was 54.19 dB SPL during modal
phonation and 60.31 during raised phonation. Images during modal phonation show a
convergent glottis with slightly separated vocal folds while raised phonation show a
convergent glottis with a larger separation of the vocal folds.
Conclusion: This study revealed that during raised phonation there is a greater
separation of the vocal folds and a convergent glottis. This change in configuration was
found to be consistent with an increase in phonation intensity and the amplitude of sound.
Relevance to the Current Work: Both this study and the current study use rabbit
larynges to examine properties of phonation. This study provides baseline information
regarding using rabbit larynges too study the voice.
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Williamson, I. J., Matusiewicz, S. P., Brown, P. H., Greening, A. P., Crompton, G. K. (1995).
Frequency of voice problems and cough in patients using pressurized aerosol inhaled
steroid preparations. European Respiratory Journal, 8(4), 590-592.
doi:10.1183/09031936.95.08040590
Purpose of the Study: Local side effects of ICs treatment for asthma are well known and
have been studied in various study designs. Due to variety of study designs, a large range
in the prevalence of dysphonia and oral candidiasis has been reported. The purpose of
this study is to document the prevalence of voice disorders and throat symptoms in
individuals using inhaled steroids to treat asthma. Pressurized aerosol, metered dose, and
inhaled corticosteroid preparations were compared in the study.
Method: Participants included 269 patients attending the chest clinic at Northern
General Hospital in Edinburgh who completed an interview-based questionnaire to gather
information related to inhaler usage, dose frequency, and treatment duration. Additional
questions were asked concerning the presence of local oropharyngeal adverse effects and
dysphonia. When symptoms were reported, frequency of occurrence was rated by most
days or every day. Additionally, a control group of 100 patients were randomly selected
from a diabetic out-patient clinic to complete the survey.
Results: Results indicate 58% (147) of participants using steroid inhalers reported
having voice or throat symptoms while only 13% (12) of the control participants to voice
or throat symptoms. Symptoms were more commonly reported by women than men
however there were not correlations between symptoms and age, smoking status, type of
steroid aerosol use, dose frequency, duration of treatment, or use of other medication. It
was found that throat symptoms increased in prevalence in those prescribed higher doses

78
of inhaled steroids. As reported, 67% (172) of patients using steroid MDI had an inhaler
induced cough, throat symptoms, or voice symptoms, however 6% (11) reported these
symptoms preceded steroid treatment. Approximately 1/3 of participants reported throat
clearing and huskiness of the voice as symptoms of the medication. Overall,
approximately 2/3 of participants experienced at least one local side effect of inhaled
steroid usage.
Conclusion: Inhaled steroids have been proven to be useful in managing asthma
symptoms, however local side effects have been frequently reported. The researchers of
this study conclude that there is a high prevalence of local adverse effects in use of
pressurized metered dose steroid aerosols for asthma treatment.
Relevance to the Current Work: The current work studies adverse effects of
ICS on aerodynamic parameters of the voice. This study provided data on the frequency
of throat and voice problems due to asthma treatment, providing justification for
completing further research to improve asthma treatment.
Witt, R. E., Regner, M. F., Tao, C., Rieves, A. L., Zhuang, P., & Jiang, J. J. (2009). Effect of
dehydration on phonation threshold flow in excised canine larynges. Annals of Otology,
Rhinology, & Laryngology, 118(2), 154–159.
https://doi.org/10.1177/000348940911800212
Purpose of the Study: The purpose of this study was to experiment and investigate the
effects of vocal fold surface dehydration on PTF in ex vivo canine larynges. The
researchers used a benchtop setup similar to the setup developed by Jiang and Titze
(1993). It was predicted that with an increase in surface dehydration, PTF would also
increase.
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Method: This study involved 11 canine larynges that were extracted after
sacrifice for other experimental studies. The subjects were divided such that 8/11 were
used as the experimental group which underwent dehydration, 2/11 were used as control
larynges, and 1/11 larynx was used as a control and then underwent dehydration. Prior to
experimental trials, excess tissue was dissected away to expose the true vocal folds and
allow for insertion of micrometers in arytenoid cartilage. Each larynx was then mounted
to the benchtop setup, as outlined by Jiang and Titze (1993). For the control trials,
humidified air was passed through the pseudolung and the vocal folds were hydrated
using 0.9% saline solution between trials. For the experimental group, the humidifier was
removed from the pseudolung apparatus and no saline solution was applied to the surface
of the vocal folds between trials. During the dehydration trials, each larynx underwent 23
series of 10-second periods of phonation with dry airflow through the vocal folds, then a
3-second rest period. PTP and PTF onset were recorded. The control group received a
similar series of 23 trials, however the 10-second period of phonation consisted of
humidified air passed through the vocal folds with saline solution applied during the 3second rest period.
Results: Results showed that PTF significantly increased as dehydration
increased. It was shown that there was a statistically significant difference between initial
and final PTF in the dehydration group. It was also shown that PTF changed and was
dependent on the level of dehydration from trial to trial. The initial PTF in dehydrated
larynges ranged from 133.9 mL/s to 661.9 mL/s. The final PTF values ranged from 196.5
mL/s to 1,219.2 mL/s.
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Conclusion: The results of this study indicate that an increase in vocal fold
surface dehydration leads to a statistically significant PTF increase. This finding suggests
that for vocal fold pathologies causing surface dehydration, PTF may be a reliable
clinical tool to examine vocal function.
Relevance to the Current Work: This study used PTF as the main aerodynamic
measurement to examine vocal fold function and health. Similarly, in the current study,
PTF is used to examine the health of both treated and control group vocal folds. This
study compared PTF in an experimental trial and in control groups, just as the current
study does. Additionally, this study uses saline solution for the control group, similarly,
the current study uses saline solution treatment in the control group. Saline solution is
also used throughout trials to ensure hydration is maintained in the vocal folds during
trials in both studies.
Zhuang, P., Sprecher, A. J., Hoffman, M. R., Zhang, Y., Fourakis, M., Jiang, J. J., & Wei, C.
(2009). Phonation threshold flow measurements in normal and pathological phonation.
The Laryngoscope, 119(4). doi: 10.1002/lary.21537
Purpose of the Study: The purpose of this study was to examine PTF in human subjects.
This study compared PTF in individuals with normal voices, vocal fold nodules, and
vocal fold polyps. This study examined the effectiveness of using PTF as an aerodynamic
measure to detect vocal fold pathologies.
Method: Participants included 40 individuals with healthy vocal folds, 21
individuals with vocal fold nodules, and 23 individuals with vocal fold polyps.
Participants sustained /a/ to measure MFR and PTF. Subjects practiced until they felt
comfortable with the procedure. Subjects phonated a sustained /a/ into a cardboard tube
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placed rested above the tongue ~1 in. into the mouth (to standardize vocal tract). To
obtain MFR recordings, subjects maintained intensity of 72 dB w/ visual feedback for 2-3
seconds. MFR trail repeated 5 times w/ subjects resting 3-5 seconds between recordings.
PTF was recorded by initiating phonation at a soft intensity and decrease intensity over 35 seconds until no phonation was detected PTF was estimated as the airflow at the point
where phonation ceased (50 dB). Each subject repeated the PTF trial 10 times, resting for
5-6 seconds between recordings
Results: Significant differences in PTF between normal voices and individuals
with vocal fold polyps was detected. There was no statistical difference in individuals
with nodules. Additionally, there was a statistically significant difference in males
compared to females.
Conclusion: PTF is a significant aerodynamic measure that can be used to assess
vocal fold pathologies like polyps. PTF was found to be sensitive to gender.
Relevance to the Current Work: The current study uses PTF to examine the
health of excised vocal folds. This study demonstrates that PTF is an effective measure of
different vocal fold pathologies, which validates the use of PTF in the current study.
Zhuang, P., Swinarska, J. T., Robieux, C. F., Hoffman, M. R., Lin, S., & Jiang, J. J. (2013).
Measurement of phonation threshold power in normal and disordered voice production.
Annals of Otology, Rhinology, & Laryngology, 122(9), 555–560.
https://doi.org/10.1177/000348941312200904
Purpose of the Study: Aerodynamic parameters are useful clinically as they provide
objective, quantitative data to reflect vocal fold health. Both PTP and PTF are valuable
and are sensitive to various laryngeal changes. The purpose of this study was to examine
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Phonation Threshold Power (PTW) as an aerodynamic measure that combines PTP and
PTF. Examiners evaluated PTW in normal subjects, and subjects with vocal fold
disorders in order to determine its effectiveness as an aerodynamic measurement in
distinguishing between disordered and normal voices.
Method: Participants included 100 subjects with normal voice function, 22
individuals with vocal fold cysts, 72 subjects with vocal fold polyps, and 19 subjects with
vocal fold mobility disorders participated in this study. PTF was measured using
methods established by Zhuang et al. (2013) where the subject sustained /a/ into a
carboard tube. Each subject started phonation at a soft intensity and over 3-5 seconds
decreased intensity until phonation ceased. PTF measurements were repeated 3 times for
each subject. PTP was measured by placing a nose clip and face mask on the participant
with an oral tube placed 2 cm into their mouth. Participants were then asked to say /pi/ 67 times per breath gradually increasing their volume until /i/ was clearly produced. PTW
was then calculated as a product of PTP and PTF.
Results: It was found that PTP, PTF, and PTW were different between each
experimental group. In individuals with vocal fold polyps, all parameters decreased after
excision. PTF in normal, mass lesion, and movement disorders were reported as
0.09±0.04, 0.18 ± 0.08, and 0.22±0.12 L/s. PTP was reported in normal, mass lesion, and
movement disordered subjects as 4.22 ± 1.02, 7.20 ± 1.84, and 6.65 ± 2.09 cm H2O.
Lastly, PTW was reported for normal, mass lesion, and movement disorder groups as
0.38±0.20, 1.28±0.68, and 1.62±0.77 cm H20 x L/s.
Conclusion: It was found that PTW is sensitive to changes due to lesions and
vocal fold mobility disorders and can be observed after mass lesion excision. It is
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concluded that PTW could be a clinically useful parameter for evaluating aerodynamic
inputs of the voice.
Relevance to the Current Work: This study relates to the current work as it
examines aerodynamic parameters in the voice with different vocal fold pathologies. The
current study utilizes PTP and PTF in combination to evaluate vocal fold health in
excised rabbit larynges after ICS treatment. This study provides information and research
on the value of using both PTP and PTF in aerodynamic research.
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APPENDIX B
Materials
Materials for Dissection
• Dissection table
• Dissection mats
• Lab sink
• Room temperature water
• Overhead light and drawing table
• #11 size X-acto™ knife
• Stainless steel disposable scalpels (size 15)
• Hemostatic forceps (4)
• Manicure scissors
• Medical suture (silk black braided 45 cm suture, 24 mm needle)
• White, nitrile, powder free gloves
• Face masks
• Disposable plastic aprons
• Safety goggles
• Phosphate-Buffered Saline (PBS) solution
• Test tubes
• ThermoScientific ™ freezer
• Food grade refrigerator
• Styrofoam box
• Cryogenic gloves
• Sharpie Permanent Marker
• Red hazardous waste box (for scalpel and suture needle disposal)
• Sani-Cloth™ germicidal disposable wipes
• Digital caliper (UltraTECH™ no. 1433)
• Digital scale (Ozeri Model ZK14-S™)
Materials for data acquisition
• Dell computer
• Dell computer monitor
• PowerLab™ data acquisition hardware (AD Instruments)
• LabChart™ data acquisition software (AD Instruments
• Microphone (Model SM-48,Shure, Niles, IL)
• High-speed camera (KayPentax, Montvale, NJ)
• Medical-grade air tank (2) containing compressed, low-humidity air (30 psi, <1% relative
humidity)
• Physiological pressure transducer (Model MLT844, AD Instruments)
• Sphygmomanometer (AD Instruments)
• Syringe (25 cc/ml)
• Pressure calibration block
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•
•
•
•
•
•
•

Gauze (to decrease reverberation under pressure transducer)
Velcro™ for securing transducers during calibration and data collection
Pneumotach Calibration Unit (MCU-4, Glottal Enterprises)
Audio Output Extension
Bose™ Amplifier
Pulse transducer (AD Instruments)
AcuRite™ Hygrometer (Model 01083M)

Materials for benchtop and phonation trials
• Anterior (one) and lateral (two) Micropositioners (Model 1460, Kopf Industries)
• Micropositioner single prong attachments (Kopf Industries)
• Plastic syringe tip (25 cc/ml)
• Tubing
o Vinyl: 1 ½” ID outer diameter (OD), 1” inner diameter (ID)
o Clear Vinyl: 1 1/8” OD, 7/8” ID; 1”OD, ¾"ID; ¾" OD, ½" ID; 7/8” OD, 5/8” ID;
5/8” OD, ½" ID; ½" OD, 3/8” ID; 3/8” OD, ¼" ID; 5/16” OD, 3/16” ID; 3/16”
OD, 1/8” ID
• Respiratory flow head transducer (Model MLT300L, AD Instruments, Sydney Australia)
• Flow head meters (Model MLT300L, AD Instruments)
• TheraHeat™ Humidifier (Model RC700000, Smiths Medical, Dublin, OH)
• Distilled water
• 20 cm foam-insulated aluminum custom pseudolung
• Teflon tape™
• Cable ties
• Screwdriver
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APPENDIX C
LabChartTM Protocol, Computer Set-up
1. Power on the computer (DellTM), desktop (DellTM), then PowerLabTM unit.
2. Open LabChartTM 8 Application
a. See pop-up, “Scanning for Devices”
b. “Powerlab 8/35” and “Playback File” should be selected, if not, verify that power
to PowerLab is turned on and then select “device scan” again
c. Click “OK”
d. On the “Welcome Center” screen, select “New”
e. In the upper right corner, select “start”
i. Allow LabChart to run for 15 minutes—the program requires sufficient
time to warm up
3. Input channel settings
a. In the upper left corner of LabChart window, select “Setup” tab --> channel
settings
b. Verify that the following settings are applied:
i. Microphone: sampling rate 40 k/s; range 10 mV; units mV
ii. Pressure: sampling rate 1 k/s; range 20 mV; units mmHg
iii. Flow: sampling rate 1 k/s; range 200 mV; units mV
iv. High speed trigger: sampling rate 1 k/s; range 2 V; units V
c. Units will be set during specific pressure and flow calibration
d. Press “OK” in the bottom right corner when settings are accurate
4. Add a comment that settings were double- checked
a. See a word box on the upper right part of the screen
i. Type in “settings”
ii. In the drop-down box to the left of the text box, make sure it is set to “All”
iii. Press the “Add” button to the right of the text box
1. You can drag the comment to be closer to the actual moment of
change by hovering the mouse over the small black box at the
bottom of the screen, directly below the comment. When a white
left/right arrow pops up, you can drag the comment
5. To return to the live recording of data, press the button in the bottom right corner entitled
“Show latest data”
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APPENDIX D
Pressure Calibration, LabChartTM Protocol
1. Zero the pressure transducer before collecting data
a. Attach the pressure transducer to the clear piece with the white cap
i. Pinch the clear prongs together and fit circle around the golden piece’s rim
b. Attach the pressure transducer to a small wooden block for stability.
c. Fasten the transducer wire between the Velcro pieces on the benchtop.
d. Attach the manometer (sphygmomanometer dial piece) via the blue stop cock
i. The air-tight screw end should attach to the outlet on the stop cock that is
180 degrees from the tube that attaches the manometer
ii. Remove the white stop cock on the pressure transducer to open it to
atmospheric pressure
iii. The hand within the manometer dial should be within the small rectangle
at the bottom when zeroing
e. Make sure that the pressure transducer is stable
f. On LabChart, press the start button to collect data for approximately 3 seconds
i. Press stop
ii. Highlight most recent section of blue data
1. Click on “Pressure” drop down box on right side of screen
2. Select “Bridge Amp”
3. Set range to 20 mV
4. Do not set a low pass value
5. Do not check “Mains filter” box
6. Press “zero” button
7. Click “OK”
iii. Leave a comment noting that pressure has been zeroed
1. Alt+ p (pre-set comment)
2. Add the white cap back to the clear piece
2. Take the syringe (25 cc/ml) and pull the plunger out to the end of the syringe
3. Add the syringe to the open outlet on the stop cock
4. Press “start” on LabChart
5. Insert plunger into syringe until the manometer dial reads 40 mmHg—hold this for 5
seconds
a. Add a comment: Alt+ 4 (pre-set comment indicating 40 mmHg)
6. Press “stop”
7. At the bottom of the screen, adjust the horizontal scaling to approximately 50, or until the
two bumps are visible without needing to scroll
8. Highlight the two bumps by starting at the “zero pressure” plateau and finishing at the 40
mmHg plateau
9. Click the pressure drop down box (on right side)
a. Click “Units Conversion”
b. On the bottom left side of the popup window should be a + and – box; press the +
button until you can see both bumps on the small graph
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c. Click the Units Conversion “on” button on the right upper corner of the popup
window
d. Click your cursor on the first plateau
i. Click the arrow button next to “Point 1”—a value should automatically
appear
ii. Manually insert a “0” in the next text box
iii. In the “Units” drop down box, select “mmHg”
e. Click on the second plateau
i. Click the arrow button next to “Point 2”—a higher value should
automatically appear
ii. Manually insert a “40” in the next text box
f. Click “OK”
g. Insert pre-set comment “40 mmHg”: Alt+ c
h. Disconnect pressure transducer from pressure calibration box and attach to the
trachea mount located on the benchtop
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APPENDIX E
Flow Calibration, LabChartTM Protocol
1. Zero the spirometer before collecting data
a. Remove the tubes from both sides of the flow head meter located on the benchtop
apparatus.
i. Keep the position of the flow head steady while you run 3 seconds of data
collection
ii. Click “stop”
iii. Highlight the most recent flow signal (green line)
iv. On the “Flow” dropdown box, click “Spirometer”
1. Set the Range to 200 mV
2. Set the Low Pass to 100 Hz
3. Do not check the “Invert” box
4. Click “Zero” button
5. Click “Ok”
b. Using the pre-set comment Alt+F, leave comment that zeroing occurred (after
pressing the “start” button)
2. Attach the flow head meter (via the blue piece) to the input on the top of the pneumotach
calibration unit.
a. Switch on the pneumotach calibration unit power using the switch on the back of
the unit; it should make a few beeps
b. Using the switches on the calibration unit, set the Flow rate to “½” and the liter to
“1”
c. Default mode on unit should be on “flow”
d. Select “start” on LabChart software
e. Flip up the “start” switch on the calibration unit; you should hear the machine
take 3 inhalations and 3 exhalations
f. Once the calibration unit has completed inhalations and exhalations stop data
acquisition on LabChart software
g. Select the middle exhalation (“up” plateau) whole single signal
h. Click the “Flow” dropdown box
i. Select “Spirometry Flow”
j. Next to “Flow Head”, click MLT 300 L
k. Click “Calibrate”
l. Insert 1L in injected volume
m. Click “ok”
3. Leave a comment noting that calibration occurred (after pressing “start” button)
a. Alt+ 1 (pre-set comment)
4. Verify that channel 3 (flow channel) is now in L/s
5. Reattach the flow head meter to the tubes under the benchtop setup. The arrow on the
flow head meter should point in the direction of flow (left). Do not remove the clear tube
attachments between the Lab Chart box and the flow head meter.
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APPENDIX F
Rabbit Tissue Dissection and Preparation Protocol
Procure rabbit larynges
1. Obtain all animal tissues from the University of Utah. All in vivo animal procedures were
completed by researchers at the University of Utah. They administered twice-daily doses
of either inhaled combination corticosteroids (salmeterol fluticasone propionate) or
nebulized isotonic saline to in vivo experimental and control rabbits, respectively. Then,
they sacrificed the rabbits and flash froze rabbit larynges in phosphate buffered solution
2. Transport larynges to the Taylor Building Annex on Brigham Young University campus
using a Styrofoam container with dry ice, supplied by researchers from the University of
Utah
3. Store rabbit larynges procured from the University of Utah in a commercial
ThermoScientificTM freezer at –80° Celsius
Thaw frozen larynges
1. Remove larynges from freezer approximately 30 minutes before beginning dissections.
2. Fill lab sink with lukewarm water. Leave frozen larynges in water until completely
defrosted.
Fine dissection
1. Use manicure scissors and size 11 X-actoTM knife
2. Spare posterior cricoarytenoid, lateral cricoarytenoid, cricothyroid, and thyroarytenoid
muscles
3. Resect esophagus from posterior trachea and larynx, inferiorly to superiorly
4. Resect tissue superior to false vocal folds
a. Resect epiglottis
b. Resect portion of thyroid cartilage approximately 4mm superior to vocal folds
5. Identify fat pads, lateral to vocal folds and superior to anterior commissure
6. Resect false vocal folds
c. Abduct false vocal folds using forceps
d. Resect false vocal folds with anterior to posterior incision, starting at anterior
commissure
2. Resect excess tissue lateral, superior, and posterior to true vocal folds that may affect
vocal fold vibration
a. Resect ventricular folds
Suture
1. Insert suture needle through anterior thyroid cartilage, approximately 1 mm superior to
anterior commissure
2. String through thyroid commissure, using two loops to secure suture
3. Dispose of needle in hazardous waste box
Storage
1. Temporary storage prior to data collection for no more than four hours
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b. Place completed larynges in coded vials of fresh phosphate buffered solution
c. Store vials in food-grade refrigerator to maintain tissue hydration
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APPENDIX G
Data Acquisition Protocol
These procedures occur immediately following pressure and flow calibration and specimen fine
dissection. To collect data on pressure and flow of phonation, at least two research assistants
must work together, one using (1) LabChart on the computer and the other performing (2)
Mounting and Air responsibilities at the benchtop:
1. LabChart:
a. Press “start” before trial begins
b. Manually type “trial 1” in text box, insert at channel 1 (microphone channel) by
pressing enter
c. At the onset of phonation, press Alt+ O (pre-set comment)
d. At the steady-state of phonation, press Alt+ S (pre-set comment)
e. At the cessation of phonation, press Alt+T (pre-set comment)
f. Press “stop” button if needed
i. Ex. need to spray the larynx, adjust the micro-positioners, etc.
g. When moving on to trial 2, adjust text box to say “trial 2”, click enter to leave
comment
h. Repeat until 15 trials are complete
i. Ensure signals look normal during phonation
j. Leave additional comments regarding difficulty in phonation, extra steps for
mounting, re-recording trials for irregular signals, etc.
k. Take notes for data sheet
i. Ex. Perceptually pressed phonation, used Teflon tape, air leakage
initially—fixed by lowering micro-positioners, etc.
2. Mounting and Air:
a. Mount the rabbit larynx on a custom bench-top set-up. Use Zip Tie™ at base of
trachea to secure trachea to air flow tube and prevent air leakage. Wrap and
secure the trachea with Teflon tape as needed to prevent air leakage. Insert micropositioners at the same level into the arytenoid cartilages to adduct the vocal
folds. Tie suture string to anterior elongation post; pull until string is taut, but not
too tight. Ensure larynx is sitting up straight and is secure.
b. Using a commercial light and iPhone camera, take still images of mounted
larynges for visual-perceptual analysis
c. Turn air tank on using hand-dial until steady phonation is perceived. After
approximately four seconds, turn the air tank off quickly.
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APPENDIX H
Data Segmentation and Analysis Protocol
1. Selecting Signals for Segmenting
a. Open Lab Chart TM version 8
b. Open the file from Desktop folder “LabChart Data”
c. Select the pre-collected animal signals that you want to segment
d. Select “File” –> “Save Selection”
i. Rename file and save in designated folder
ii. Do not save changes to main LabChart Data File
e. Open new file to segment
2. Placing Onset and Offset
a. Zoom in to 2:1
b. Analyze the waveform and place onset on the second peak after the waveform
begins to look semi-periodic.
c. Examine both periodicity and amplitude of waveform to determine where offset is
and place marker on the last semi-periodic peak before signal dies out
i. Note: You can use the audio from the acoustic signal to help identify the
approximate location of onset and offset.
3. Marking trial errors
a. Identify any trials where errors occurred, and trials were repeated
b. Change all of the markers in discarded trials so that they are not tagged
“phonation onset” and “phonation offset”. Change “phonation onset” to “signal
start” and “phonation offset” to “signal end”. This is so that these trial errors will
not be accounted for when Matlab analysis is performed.
c. Keep detailed notes on which trials were in error and where they are in the data.
4. Export Segments
a. Click “File” -> “save” and save segmented file as a new file
b. Select “File”-> “export” to convert file to txt file
c. Save the txt files in the correct folder and upload to custom Matlab program for
further analysis
5. Open Matlab application
a. Click “Open File” -> select segmented txt file
b. Drag the yellow boxes on the screen out of the way
c. Count trials to verify that all 15 trials have been included in txt file
6. Selecting Results
a. Move red markers on microphone signal data to surround one trial of phonation
i. Note the placement of the vertical lines between pressure signal peaks.
The red markers should be placed as close to these lines as possible but
must be within the vertical markers.
b. Select “play” in order for application to register line placement
7. Select “save”
a. Save as “rabbit#_trial#” It will save as a CSV file (both sound and excel file)
8. Open excel file to see pressure, flow, and resistance values for phonation onset, steady
phonation, and offset phonation
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APPENDIX I
Thesis Timeline
5/19

•

6/19

•

10/19
•

11/19
•

12/19
•

1/20

•

Training for lab use, including orientation to instruction manuals and videos in cloud
storage, hard drive storage, lab computer and program usage, and pressure and flow
calibration.
Training in fine dissection of rabbit larynges and benchtop setup. Trained in collecting
acoustic, aerodynamic, and visual data.
Fine dissection and collection of acoustic, aerodynamic, and visual data for experimental
larynges
Training for data segmentation of raw data on LabChart™ to prepare for upload
to MatLab ™ program for analysis
Preparation for control rabbit acquisition for further data collection
Fine dissection and collection of acoustic, aerodynamic, and visual data for all control
larynges

2/20-3/20
• Maintain lab
o Back-up collected data on hard drive
o Computer maintenance via crash-plan download
o Medical grade compressed air USP gas cylinder replacement
o Reset precautionary ThermoScientific™ battery
4/20

•

6/20

•

8/20

•

Complete data analysis of phonation pressure and flow using MatLab and Audacity
programs performed by Amber Prigmore and Meg Hoggan
Analyze data for significant differences between experimental and control groups in
phonation pressure and flow completed by Dr. Ray M. Merrill, Ph.D., using SPSS,
version 24 and the Statistical Analysis System, version 9.4
Write prospectus
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11/20
•

12/20
•

1/21

•

Edit prospectus document
Complete Prospectus meeting with thesis committee, discussing specific thesis questions,
importance of current study, and protocol for completing statistical analysis
Edit Prospectus documents to align with feedback received from thesis committee

2/21
•
•

Prepare for thesis defense by completing first written draft of thesis document
Schedule oral thesis defense

3/21
•

Complete oral thesis defense

